<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>3
<FILENAME>j7231_ex2d1.htm
<DESCRIPTION>EX-2.1
<TEXT>
<html>



<head>



<title>  </title>



</head>



<body>



<div style="font-family:'Times New Roman';">



<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>



<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit

2.1</font></b></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ASSET

PURCHASE AND LICENSE AGREEMENT</font></b></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">between:</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">Restoragen, Inc.</font></b><font style="text-transform:uppercase;">,</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">a Delaware corporation;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">and</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">Amylin Pharmaceuticals, Inc.</font></b><font style="text-transform:uppercase;">,</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">a Delaware corporation</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>





<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="1" width="25%" noshade color="black" align="center">



</font></div>





<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dated as of December&nbsp;24, 2002</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>





<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="1" width="25%" noshade color="black" align="center">



</font></div>





<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ASSET

PURCHASE AND LICENSE AGREEMENT</font></b></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">This Asset

Purchase and License Agreement</font></b> (the <i><font style="font-style:italic;">&#147;</font><b><font style="font-weight:bold;">Agreement</font></b>&#148;</i>) is entered into and effective

as of December&nbsp;24, 2002 by and between <b><font style="font-weight:bold;text-transform:uppercase;">Restoragen, Inc</font></b><font style="text-transform:uppercase;">.</font>, a Delaware

corporation, located at 3820&nbsp;NW 46<sup>th</sup> Street, Lincoln, Nebraska

68524 (<i><font style="font-style:italic;">&#147;</font><b><font style="font-weight:bold;">Restoragen</font></b>&#148;</i>), and <b><font style="font-weight:bold;text-transform:uppercase;">Amylin Pharmaceuticals, Inc.</font>,</b> a Delaware

corporation, located at 9373&nbsp;Towne Centre Drive, San Diego, California

92121 (<i><font style="font-style:italic;">&#147;</font><b><font style="font-weight:bold;">Amylin</font></b>&#148;</i>).&#160; Certain capitalized terms used in this Agreement are defined in <b><i><font style="font-style:italic;font-weight:bold;">Exhibit&nbsp;A</font></i></b>.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">Recitals</font></b></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;letter-spacing:-.15pt;text-transform:uppercase;">Whereas</font></b><font style="letter-spacing:-.15pt;">,

this Agreement sets forth the terms and conditions upon which

(a)&nbsp;Restoragen shall sell to Amylin, and Amylin shall purchase from

Restoragen, certain assets of Restoragen, free and clear of Encumbrances (as

defined below), and (b)&nbsp;Restoragen shall grant to Amylin a non&#150;exclusive,

worldwide license under certain manufacturing patent rights, each as more fully

described herein.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;letter-spacing:-.15pt;text-transform:uppercase;">Now Therefore</font></b><font style="letter-spacing:-.15pt;">, in consideration of the foregoing and the covenants and premises

contained in this Agreement, and intending to be legally bound hereby, the

parties agree as follows:</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">Agreement</font></b></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The parties to this Agreement, intending to be legally

bound, agree as follows:</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;"><a name="_Toc22988627"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1.</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;text-transform:uppercase;">Sale of Assets; Related

Transactions.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><a name="_Toc22988628"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1.1</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Sale of Assets</font></b>.&#160; Restoragen shall cause to be sold, assigned, transferred,

conveyed and delivered to Amylin, at the Closing (as defined below), good and

valid title to the Assets (as defined below), free of any Encumbrances, on the

terms and subject to the conditions set forth in this Agreement.&#160; For purposes of this Agreement, <b><i><font style="font-style:italic;font-weight:bold;">&#147;Assets&#148;</font></i></b> shall mean

and include each of the assets listed on <b><i><font style="font-style:italic;font-weight:bold;">Exhibit&nbsp;B</font></i></b>

hereto.&#160; Further, upon the Closing,

Restoragen hereby grants to Amylin a non-exclusive, worldwide, royalty-free,

irrevocable, perpetual license, with the right to sublicense through multiple

tiers of sublicense, under all patents, patent applications and pending patent

disclosures owned by Restoragen on the Closing Date that would be infringed by

the development, manufacture, use, sale or import of Products but for such

license (but excluding the Manufacturing Patents and the Restoragen Patent

Portfolio).</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><a name="_Toc22988629"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1.2</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">License Grant</font></b>.&#160; Subject to the terms and conditions of this Agreement, Restoragen

hereby grants to Amylin during the Payment Term a non-exclusive, worldwide,

royalty-free license, with the right to sublicense through multiple tiers of

sublicense, under the Manufacturing Patents and Know-How to develop, make, have

made, use, sell, offer for sale, have sold and import Products (the <i><font style="font-style:italic;">&#147;</font><b><font style="font-weight:bold;">License</font></b>&#148;</i>).&#160; For purposes of clarification, notwithstanding the definition of

Manufacturing Patents or the contents of <b><i><font style="font-style:italic;font-weight:bold;">Exhibit&nbsp;F</font></i></b> hereto, the parties

acknowledge and agree that the License is granted under all patents and patent

applications owned by Restoragen on the Closing Date that would be infringed by

the manufacture of Products in the absence of a license thereunder, regardless

of whether such patents and patent applications are listed in <b><i><font style="font-style:italic;font-weight:bold;">Exhibit&nbsp;F</font></i></b>.</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='1',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1.3</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Assumption

of Liabilities</font></b>.&#160; Amylin is not assuming or in any way

becoming liable or responsible for any Liability of Restoragen, except as

expressly set forth in this Section&nbsp;1.3.&#160;

On the Closing Date, Amylin agrees to assume, and perform and pay in

accordance with their respective terms, all obligations arising with respect to

periods commencing after the Closing under the Acquired Contracts and the

obligations to Third Parties described on <b><i><font style="font-style:italic;font-weight:bold;">Exhibit&nbsp;C</font></i></b> (the <b><i><font style="font-style:italic;font-weight:bold;">&#147;Assumed Liabilities&#148;</font></i></b>).&#160; Without limiting the generality of the

foregoing and notwithstanding anything to the contrary contained in this Agreement,

the &#147;Assumed Liabilities&#148; shall not include, and Amylin shall not be required

to assume or to perform or discharge:</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any

Liability of any stockholder of Restoragen or any other Person, except for

Restoragen;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any

Liability of Restoragen arising out of or relating to the execution, delivery

or performance of any of the Transactional Agreements;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(c)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any

Liability of Restoragen for any fees, costs or expenses of the type referred to

in Section&nbsp;16.2(a) of this Agreement;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(d)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any

Liability of Restoragen arising from or relating to any action taken by

Restoragen, or any failure on the part of Restoragen to take any action, at any

time after the Closing Date;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(e)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any

Liability of Restoragen arising from or relating to any claim or Proceeding against

Restoragen, including, without limitation, any claim or Proceeding against

Restoragen relating to clinical trials conducted by or on behalf of Restoragen

prior to the Closing Date;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(f)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any

Liability of Restoragen for the payment of any Tax;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(g)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any

Liability of Restoragen to any employee or former employee of Restoragen;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(h)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any

Liability of Restoragen to any of its stockholders, Affiliates or their

respective Representatives;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(i)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any

Liability under any Acquired Contract, if Restoragen shall not have obtained,

prior to the Closing Date, any Consent required to be obtained from any Person

or Court Approval with respect to the assignment or delegation to Amylin of any

rights or obligations under such Acquired Contract;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(j)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any

Liability under any Contract to which Restoragen is a party or to which any of

the Assets are subject, other than the Acquired Contracts;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(k)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any

Liability that is inconsistent with or constitutes an inaccuracy in, or that

arises or exists by virtue of any Breach of, (x)&nbsp;any representation or

warranty made by Restoragen in any of the Transactional Agreements, or

(y)&nbsp;any covenant or obligation of Restoragen contained in any of the

Transactional Agreements; or</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='2',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(l)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any

other Liability that is not referred to specifically in the second sentence of

this Section&nbsp;1.3.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1.4</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Purchase Price</font></b>.&#160; As consideration for the sale of the Assets and the grant

of the License to Amylin and contingent upon the Closing:</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Amylin

will pay to Restoragen up to an aggregate of Four Million Dollars ($4,000,000)

in cash as follows:</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(i)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Three

Million Three Hundred Thousand Dollars ($3,300,000) at the Closing; and</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(ii)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Seven

Hundred Thousand Dollars ($700,000) within thirty (30) days of receipt of the Study

Report, provided that either (A)&nbsp;the data contained in the Study Report

meets or exceeds the Development Criteria or (B)&nbsp;the data contained in the

Study Report does not meet or exceed the Development Criteria but Amylin elects

to move forward with development of the GLP&#150;1 Product as described in

Section&nbsp;8.2; and</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>during

the Payment Term, Amylin shall make the Product-related payments specified in

Section&nbsp;9 hereof.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><a name="_Toc22988631"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1.5</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Sales Taxes</font></b>.&#160; Restoragen shall bear and pay, and shall reimburse Amylin and

Amylin&#146;s affiliates for, any sales taxes and use taxes that may become payable

in connection with the sale of the Assets to Amylin or in connection with any

of the other Transactions.&#160; Amylin shall

bear and pay, and shall reimburse Restoragen and Restoragen&#146;s Affiliates, for

any transfer taxes, documentary charges, recording fees or similar taxes,

charges, fees or expenses that may become payable in connection with the sale

of the Assets to Amylin or in connection with any of the other Transactions.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><a name="_Toc22988632"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1.6</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Allocation of Purchase Price</font></b>.&#160; Within thirty (30) days following the

Closing, Amylin shall deliver to Restoragen a statement setting forth Amylin&#146;s

good faith proposal of the manner in which the consideration referred to in

Section&nbsp;1.4 is to be allocated among the Assets.&#160; The allocation prescribed by such statement shall be conclusive

and binding upon Restoragen and Amylin for all purposes, and Restoragen shall

not file any Tax Return or other document with, or make any statement or

declaration to, any Governmental Body that is inconsistent with such

allocation.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><a name="_Toc22988633"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1.7</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Closing.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The

closing of the sale of the Assets to Amylin (the &#147;Closing&#148;) shall take place at

the offices of Cooley Godward <font style="text-transform:uppercase;">llp</font>

in San Diego, California or at another mutually agreeable location, at 10:00

a.m. on such date within five (5) days following the entry of the Approval

Order as Amylin and Restoragen agree; <i><font style="font-style:italic;">provided, however</font></i>, that if any condition

set forth in Section&nbsp;6 has not been satisfied as of the date designated,

then Amylin and Restoragen may mutually agree to postpone the Scheduled Closing

Time by up to five (5) business days.&#160;

For purposes of this Agreement, <i><font style="font-style:italic;">&#147;</font><b><font style="font-weight:bold;">Scheduled Closing Time</font></b>&#148;</i> shall mean the time and date as

of which the Closing is required to take place pursuant to this Section&nbsp;1.7(a);

and <i><font style="font-style:italic;">&#147;</font><b><font style="font-weight:bold;">Closing Date</font></b>&#148;</i> shall mean the time and date as

of which the Closing actually takes place.</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='3',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:8.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>At

the Closing:</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(i)</font></b><font size="1" style="font-size:8.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Restoragen

shall execute and deliver to Amylin such bills of sale, endorsements,

assignments and other documents as may (in the reasonable judgment of Amylin or

its counsel) be necessary or appropriate to assign, convey, transfer and

deliver to Amylin good and valid title to the Assets free of any Encumbrances.&#160; Without limiting the generality of the

foregoing, Restoragen shall execute and deliver the Bill of Sale, Assignment

and Assumption, substantially in the form attached hereto as <b><i><font style="font-style:italic;font-weight:bold;">Exhibit&nbsp;D</font></i></b> (the <b><i><font style="font-style:italic;font-weight:bold;">&#147;Bill of Sale&#148;</font></i></b>), with respect to the Assets and such

other instruments as Amylin shall reasonably request, including, without

limitation, assignment agreements with respect to the Restoragen Patent

Portfolio;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(ii)</font></b><font size="1" style="font-size:8.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Amylin

shall execute and deliver the Bill of Sale;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(iii)</font></b><font size="1" style="font-size:8.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Amylin

shall pay to Restoragen $3,300,000 in cash as contemplated by Section

1.4(a)(i);</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(iv)</font></b><font size="1" style="font-size:8.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Restoragen

shall execute and deliver to Amylin a certificate (the <b><i><font style="font-style:italic;font-weight:bold;">&#147;Closing

Certificate&#148;</font></i></b>) setting forth the representations and warranties

of Restoragen that (A)&nbsp;each of the representations and warranties made by

Restoragen in this Agreement was accurate in all material respects as of the

date of this Agreement, (B)&nbsp;except as expressly set forth in the Closing

Certificate, each of the representations and warranties made by Restoragen in

this Agreement is accurate in all material respects as of the Closing Date as

if made on the Closing Date, (C)&nbsp;each of the covenants and obligations

that Restoragen is required to have complied with or performed pursuant to this

Agreement at or prior to the Closing has been duly complied with and performed

in all material respects, and (D)&nbsp;except as expressly set forth in the

Closing Certificate, each of the conditions set forth in Sections&nbsp;6.4, 6.6

and 6.7 has been satisfied in all material respects.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:1.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(v)</font></b><font size="1" style="font-size:8.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Restoragen

shall deliver, or cause to be delivered, to Amylin an itemized list of tangible

items included in the Assets, including the location where each such item is

stored or maintained.&#160; As promptly as

practicable (and in any event within thirty (30) days) after the Closing,

Restoragen shall deliver, or cause to be delivered, to Amylin or its designee

all tangible items included in the Assets or, in the case of documents,

complete and accurate copies thereof, including, without limitation, complete

and accurate copies of all patents and patent applications included in the

Restoragen Patent Portfolio, other documentation in the possession or control

of Restoragen regarding the Restoragen Patent Portfolio and any correspondence

between Restoragen and the U.S. Patent &amp; Trademark Office or any foreign

patent office with respect to the Restoragen Patent Portfolio.&#160; Restoragen shall have the right to retain,

for archival and other appropriate purposes, a reasonable number of copies of

each document provided to Amylin hereunder.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;"><a name="_Toc22988634"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.</font></b></a><font size="1" style="font-size:8.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;text-transform:uppercase;">Representations and Warranties of Restoragen.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Restoragen represents and warrants, to and for the

benefit of Amylin, as follows:</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><a name="_Toc22988635"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.1</font></b></a><font size="1" style="font-size:8.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Due Organization and Standing</font></b>.&#160; Restoragen is a corporation duly organized,

validly existing and in good standing under the laws of the State of Delaware

and has full</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='4',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">corporate power and

authority to deliver this Agreement and to carry out the provisions hereof,

subject to the receipt of the Consents described in Section 2.9, and subject to

Bankruptcy Court approval of the Transactions.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><a name="_Toc22988640"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.2</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Title To Assets</font></b>.&#160; As of the date of this Agreement, Restoragen owns, and has good,

valid and marketable title to, the Assets, and all of said Assets are owned by

Restoragen free and clear of any Encumbrances, except in each case with respect

to the Encumbrances disclosed in Part&nbsp;2.2 of the Disclosure Schedule or in

the voluntary petition for reorganization under Chapter&nbsp;11 of the

Bankruptcy Code filed by Restoragen on December&nbsp;17, 2002 in the United States

Bankruptcy Court for the District of Nebraska (the <b><i><font style="font-style:italic;font-weight:bold;">&#147;Chapter&nbsp;11 Filing&#148;</font></i></b>).<b><font style="font-weight:bold;">  </font></b>&#160;Upon receipt of the Approval Order and immediately prior to the

Closing, Restoragen will own, and have good, valid and marketable title to and

the entire interest in, the Assets, and all of said Assets will be owned by

Restoragen free and clear of any Encumbrances.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><a name="_Toc22988647"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.3</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Restoragen Patent Portfolio; Licensed Technology.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To

the knowledge of Restoragen, Restoragen has not received any written notice asserting that any

employee or independent contractor of Restoragen has any claim, right (whether

or not currently exercisable) or interest in or to the Restoragen Patent

Portfolio.&#160; Except as otherwise

disclosed in writing to Amylin, none of the Manufacturing Patents or patents or

patent applications included in the Restoragen Patent Portfolio has been

abandoned or allowed to lapse or, to the knowledge of Restoragen, rejected.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To

the knowledge of Restoragen, none of the patents or patent applications of the

Restoragen Patent Portfolio is subject to any invalidity proceeding in front

of, or has been found to be invalid by, a court of competent jurisdiction, and none of the subject matter of the Restoragen

Patent Portfolio is subject to any proceedings to which Restoragen is a

party or of which Restoragen has received written notice alleging infringement of third party rights or been found to infringe

third party rights by a court of competent jurisdiction.<b><font style="font-weight:bold;">&#160; </font></b>To the knowledge of Restoragen, Restoragen has not received any written

notice relating to any actual, alleged or suspected infringement,

misappropriation or violation of any Intellectual Property Right of another

Person arising from the practice of the inventions claimed in the Restoragen

Patent Portfolio or the Manufacturing Patents.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(c)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">DISCLAIMER.&#160;

EXCEPT AS OTHERWISE PROVIDED IN THIS AGREEMENT, RESTORAGEN DISCLAIMS ANY

AND ALL WARRANTIES EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION, WARRANTIES

OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT OF THIRD

PARTY RIGHTS AND TITLE.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988648"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.4</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Contracts.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Part

2.4 of the Disclosure Schedule identifies each Contract included in the Assets

(the <i><font style="font-style:italic;">&#147;</font><b><font style="font-weight:bold;">Acquired

Contracts</font></b>&#148;</i>).&#160; Restoragen has delivered to Amylin accurate

and complete copies of all Acquired Contracts, including all amendments and

written waivers thereto.&#160; To the

knowledge of Restoragen, each such Acquired Contract is valid and in full force

and effect.</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='5',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except

as set forth in Part&nbsp;2.4 of the Disclosure Schedule, to the knowledge of

Restoragen: (i)&nbsp;no Person is in material default under any Acquired

Contract; (ii)&nbsp;no circumstance or condition exists, that would (with or

without notice or lapse of time) (A)&nbsp;give any Person the right to declare

a default or exercise any remedy under any Acquired Contract, or (B)&nbsp;give

any Person the right to cancel or terminate any Acquired Contract; and

(iii)&nbsp;Restoragen has not waived any right under any Acquired Contract.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988650"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.5</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Compliance with Legal Requirements</font></b>.&#160; Except as disclosed in Part&nbsp;2.5 of the

Disclosure Schedule, to the knowledge of Restoragen, Restoragen has not

received, at any time, any notice or other communication (in writing or

otherwise) from any Regulatory Authority regarding (i)&nbsp;any actual or alleged

violation of, or failure to comply with, any Legal Requirement related to

obtaining Regulatory Approval for any activities of Restoragen involving the

Assets or the Licensed Technology, or (ii)&nbsp;any actual or alleged

obligation on the part of Restoragen to undertake, or to bear all or any

portion of the cost of, any remedial, corrective or response action of any

nature related to the Assets.&#160; To its

knowledge, Restoragen has delivered to Amylin an accurate and complete copy of

each report, study, survey or other document to which Restoragen has access

that addresses or otherwise relates to the compliance of Restoragen with, or

the applicability to Restoragen of, the above-described Legal Requirements.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988651"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.6</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Governmental Authorizations</font></b>.&#160; Part&nbsp;2.6 of the Disclosure Schedule

identifies each material Governmental Authorization that is held by Restoragen

related to the Assets or the Licensed Technology with respect to its use to

date in developing the Products.&#160; To its

knowledge, Restoragen has delivered to Amylin accurate and complete copies of

all of the Governmental Authorizations identified in Part&nbsp;2.6 of the

Disclosure Schedule, including all renewals thereof and all amendments thereto.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988661"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.7</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Proceedings; Orders</font></b>.&#160; Except as set forth in Part&nbsp;2.7 of the

Disclosure Schedule, there is no pending Proceeding, and, to the knowledge of

Restoragen, no Person has threatened to commence any Proceeding: (i)&nbsp;that

involves Restoragen and that relates to or might affect any of the Assets or

Restoragen&#146;s ability to grant the License (whether or not Restoragen is named

as a party thereto); or (ii)&nbsp;that challenges, or that may have the effect

of preventing, delaying, making illegal or otherwise interfering with, any of

the Transactions.&#160; There is no Order to

which Restoragen, or any of the Assets or Licensed Technology, is subject.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988662"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.8</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Authority; Binding Nature Of Agreements</font></b>.&#160; Subject to the receipt of the

Consents described in Section 2.9 and the Approval Order, Restoragen has the

absolute and unrestricted right, power and authority to enter into and to

perform its obligations under each of the Transactional Agreements to which it

is or may become a party; and the execution, delivery and performance by

Restoragen of the Transactional Agreements to which it is or may become a party

have been duly authorized by all necessary action on the part of Restoragen and

its stockholders and board of directors.&#160;

This Agreement constitutes the legal, valid and binding obligation of

Restoragen, enforceable against Restoragen in accordance with its terms,

subject to the effect of bankruptcy, insolvency, reorganization and the rights

of creditors generally.&#160; Subject to the

receipt of the Consents described in Section 2.9 and the Approval Order, upon

the execution of each of the other Transactional Agreements at the Closing,

each of such other Transactional Agreements to which Restoragen is a party will

constitute the legal, valid and </p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='6',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">binding obligation of

Restoragen and will be enforceable against Restoragen in accordance with its

terms.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988663"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.9</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Non-Contravention; Consents</font></b>.&#160; Subject to the receipt of the Approval

Order, and except as set forth in Part&nbsp;2.9 of the Disclosure Schedule,

neither the execution and delivery of any of the Transactional Agreements, nor

the consummation or performance of any of the Transactions, will directly or

indirectly (with or without notice or lapse of time):</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>to

the knowledge of Restoragen, contravene, conflict with or result in a violation

of, or give any Governmental Body or other Person the right to challenge any of

the Transactions or to exercise any remedy, or obtain any relief, under any

Legal Requirement or any Order to which Restoragen is subject that would

adversely affect the Assets or the Licensed Technology;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>to

the knowledge of Restoragen, contravene, conflict with or result in a violation

of any of the terms or requirements of, or give any Governmental Body the right

to revoke, withdraw, suspend, cancel, terminate or modify, any Governmental

Authorization that is to be included in the Assets or Licensed Technology or is

held by Restoragen and relates to the Assets or Licensed Technology;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(c)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>contravene,

conflict with or result in a violation or breach of, or result in a default

under, any provision of any Acquired Contract;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(d)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>give

any Person the right to (i)&nbsp;declare a default or exercise any remedy under

any Acquired Contract, (ii)&nbsp;accelerate the maturity or performance of any

Acquired Contract, or (iii)&nbsp;cancel, terminate or modify any Acquired

Contract; or</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(e)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>to

the knowledge of Restoragen, result in the imposition or creation of any

Encumbrance (other than Encumbrances disclosed in the Disclosure Schedule or

the Chapter&nbsp;11 Filing) upon or with respect to any of the Assets or

Licensed Technology.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Subject to the

receipt of the Approval Order, and except as set forth in Part&nbsp;2.9 of the

Disclosure Schedule, Restoragen was not, is not and will not be required to

make any filing with or give any notice to, or to obtain any Consent from, any

Person in connection with the execution and delivery of any of the

Transactional Agreements or the consummation or performance of any of the

Transactions.</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988666"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.10</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">No Royalty Obligations</font></b>.&#160;

Except as set forth in Part 2.10 of the Disclosure Schedule, Restoragen

is not a party to any Contract and is not subject to any Order obligating

Restoragen, its Affiliates or their respective sublicensees to pay royalty or

other payments to any Third Party with respect to the practice of the

inventions claimed in the Restoragen Patent Portfolio.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.11</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Brokers</font></b>.&#160;

Restoragen has not become obligated to pay, and has not taken any action

that might result in any Person claiming to be entitled to receive, any

brokerage commission, finder&#146;s fee or similar commission or fee in connection

with any of the Transactions.</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='7',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:left;text-indent:-.5in;"><a name="_Toc22988667"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">3.</font></b></a><font size="1" style="font-size:3.0pt;text-transform:uppercase;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;text-transform:uppercase;">Representations and

Warranties of Amylin.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amylin represents and warrants, to and for the benefit

of Restoragen, as follows:</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988668"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">3.1</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Authority; Binding Nature Of Agreements</font></b>.&#160; Amylin has the absolute and unrestricted

right, power and authority to enter into and perform its obligations under each

of the Transactional Agreements to which it is or may become a party, and the

execution and delivery of the Transactional Agreements by Amylin have been duly

authorized by all necessary action on the part of Amylin and its board of

directors.&#160; This Agreement and each of

the other Transactional Agreements signed at the Closing, constitutes the

legal, valid and binding obligation of Amylin, enforceable against it in

accordance with its terms.&#160; The

execution, delivery and performance of the Transactional Agreement by Amylin do

not conflict with or result in violation of or give any Governmental Body or

other Person the right to challenge any of the Transactions or to exercise any

remedy or obtain any relief under, any Legal Requirement or any Order to which

Amylin, or any of the assets of Amylin, is subject.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988669"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">3.2</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Brokers</font></b>.&#160;

Amylin has not become obligated to pay, and has not taken any action

that might result in any Person claiming to be entitled to receive, any

brokerage commission, finder&#146;s fee or similar commission or fee in connection

with any of the Transactions.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><a name="_Toc22988670"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></a></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:left;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">4.</font></b><font size="1" style="font-size:3.0pt;text-transform:uppercase;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;text-transform:uppercase;">Pre-Closing Covenants of

Restoragen.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988671"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4.1</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Access And Investigation</font></b>.&#160; Restoragen shall ensure that, at all times

during the Pre-Closing Period and upon reasonable advance notice by Amylin:

(a)&nbsp;Restoragen and its Representatives provide Amylin and its

Representatives with free and complete access to Restoragen&#146;s Representatives,

personnel and assets and to all existing books, records and other documents and

information relating to the Assets or the Licensed Technology; and

(b)&nbsp;Restoragen and its Representatives provide Amylin and its

Representatives with such copies of existing books, records and other documents

and information relating to the Assets or the Licensed Technology as Amylin may

request in good faith.&#160; Amylin

acknowledges that Restoragen has limited resources and accordingly agrees to

cooperate with Restoragen as reasonably necessary in Restoragen&#146;s performance

of the activities described in this Section&nbsp;4.1.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988672"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4.2</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Operation Of Business</font></b>.&#160; Except as otherwise contemplated in this

Agreement or ordered by the Bankruptcy Court (a <i><font style="font-style:italic;">&#147;</font><b><font style="font-weight:bold;">Conduct Order</font></b>&#148;</i>), Restoragen shall use its Best Efforts to ensure that,

during the Pre&#150;Closing Period:</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Restoragen

continues to conduct the ongoing clinical trial of GLP&#150;1 Product in

accordance with the protocol provided to Amylin and with applicable laws, rules

and regulations;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Restoragen

does not make any material change to the protocol and costs for the Study

without Amylin&#146;s prior written approval.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(c)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Restoragen

maintains the patents and patent applications included in the Restoragen Patent

Portfolio and the Manufacturing Patents;</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='8',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(d)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Restoragen

complies in all material respects with the provisions of the Acquired

Contracts;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(e)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Restoragen

stores (or causes to be stored) and maintains all inventory included in the

Assets under appropriate conditions, consistent with pharmaceutical industry

standards, specifications applicable to such inventory and applicable laws,

rules and regulations; and</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(f)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Restoragen

does not take or omit to take any action that would subject the Assets to any

lien, security interest or license.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988673"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4.3</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Filings and Consents</font></b>.&#160; Restoragen shall use its Best Efforts to

ensure that: (a)&nbsp;all filings, notices and Consents required to be made,

given and obtained by Restoragen in order to consummate the Transactions are

made, given and obtained on a timely basis; and (b)&nbsp;during the Pre&#150;Closing

Period, Restoragen and their respective Representatives cooperate with Amylin

and with Amylin&#146;s Representatives, and prepare and make available such

documents and take such other actions as Amylin may request in good faith, in

connection with any filing, notice or Consent that Amylin is required or elects

to make, give or obtain.&#160;

Further, Restoragen shall use its Best Efforts at a commercially

reasonable cost to obtain and perfect, prior to the Closing Date, an assignment

to the subject matter described in any Acquired Contract that is a letter

agreement between Restoragen and one or more inventors.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4.4</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Pleadings;

Sale Motion</font></b>.&#160; Restoragen shall promptly provide Amylin

with drafts of all documents, motions, orders, filings or pleadings that

Restoragen or any of its Representatives propose to file with the Bankruptcy

Court that relate to the consummation or approval of the Transaction Agreements

or the Transactions, and will provide Amylin with reasonable opportunity to

review and approve such filings.&#160; Within

one (1) business day of the date of this Agreement, Restoragen shall file with

the Bankruptcy Court a sale motion requesting approval of this Agreement, which

motion shall be in substantially the form provided to Amylin or its counsel

(the <b><i><font style="font-style:italic;font-weight:bold;">&#147;Sale Motion&#148;</font></i></b>).&#160; During the Pre&#150;Closing Period,

Restoragen shall not amend, modify, abandon or withdraw the Sale Motion without

Amylin&#146;s prior written consent.&#160; In

addition, during the Pre&#150;Closing Period, and subject to applicable law

(including, without limitation, the U.S. Bankruptcy Code), Restoragen shall use

commercially reasonable efforts to cause the Bankruptcy Court to reject each

Contract that relates to any of the Assets and is not an Acquired Contract.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4.5</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Notification.</font></b>&#160; During the Pre&#150;Closing Period, Restoragen shall provide

Amylin with prompt written notice of: (a)&nbsp;any event or circumstance that

would constitute a Breach of a representation or warranty made by Restoragen if

such representation or warranty had been made as of the time of the occurrence;

(b)&nbsp;any Breach of a covenant or obligation of Restoragen hereunder; and

(c)&nbsp;any event or circumstance that could reasonably be expected to make

the timely satisfaction of any of the conditions set forth in Section&nbsp;6 or

Section&nbsp;7 impossible or unlikely.&#160;

In addition, during the Pre&#150;Closing Period, Restoragen shall

provide Amylin with written notice of any inquiry, proposal or offer from any

Person relating to any Acquisition Transaction within one (1) business day of

becoming aware thereof (which notice shall include the proposed terms of any

such Acquisition Transaction), and Restoragen shall use all reasonable efforts

to ensure that, subject to any bidding order approved by the Bankruptcy Court,

Amylin </p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='9',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">has a reasonable

opportunity to offer to exceed the bid submitted by any such Person, at

Amylin&#146;s discretion.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988676"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4.6</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Best Efforts</font></b>.&#160; During the Pre-Closing Period, Restoragen shall use its Best

Efforts to cause the conditions set forth in Section&nbsp;6 to be satisfied on

a timely basis.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:left;text-indent:-.5in;"><a name="_Toc22988679"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">5.</font></b></a><font size="1" style="font-size:3.0pt;text-transform:uppercase;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;text-transform:uppercase;">Pre-Closing Covenants of

Amylin.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988681"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">5.1</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Best Efforts</font></b>.&#160; During the Pre-Closing Period, Amylin shall use its Best Efforts

to cause the conditions set forth in Section 7 to be satisfied.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:left;text-indent:-.5in;"><a name="_Toc22988683"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">6.</font></b></a><font size="1" style="font-size:3.0pt;text-transform:uppercase;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;text-transform:uppercase;">Conditions Precedent to

Amylin&#146;s Obligation to Close.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amylin&#146;s obligation to purchase the Assets and to take

the other actions required to be taken by Amylin at the Closing is subject to

the satisfaction, at or prior to the Closing, of each of the following

conditions (any of which may be waived by Amylin, in whole or in part, in

writing):</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988684"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">6.1</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Bankruptcy

Court Approval</font></b>.&#160; The Bankruptcy Court shall have entered a

final order (the finality of which may be waived by Amylin, in its sole

discretion) pursuant to Sections&nbsp;105, 363 and 365 of the Bankruptcy Code,

which order shall be reasonably acceptable to Amylin, approving the sale of the

Assets, the assignment of the Acquired Contracts and the grant of the License

to Amylin, in each case, free and clear of all Encumbrances, with a finding of

&#147;good faith&#148; within the meaning of Section&nbsp;363(m) of the Bankruptcy Code,

and such order shall be unstayed (the <i><font style="font-style:italic;">&#147;</font><b><font style="font-weight:bold;">Approval Order</font></b>&#148;</i>).</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">6.2</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Accuracy Of Representations</font></b>.&#160; All of the representations and warranties made

by Restoragen in this Agreement (considered collectively), and each of said

representations and warranties (considered individually), shall have been

accurate in all material respects as of the date of this Agreement, and shall

be accurate in all material respects as of the Scheduled Closing Time as if

made at the Scheduled Closing Time, without giving effect to any update to the

Disclosure Schedule.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988685"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">6.3</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Performance Of Obligations.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each

of the documents referred to in Sections 1.7(b)(i) and 1.7(b)(iv) shall have

been executed by each of the parties thereto and delivered to Amylin.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The

documents referred to in Section&nbsp;1.7(b)(iv) shall have been delivered to

Amylin;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(c)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All

of the covenants and obligations that Restoragen are required to comply with or

to perform at or prior to the Closing (considered collectively), and each of

said covenants and obligations (considered individually), shall have been duly

complied with and performed in all material respects.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988686"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">6.4</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Consents</font></b>.&#160;

Each of the Consents identified in Part&nbsp;2.9 of the Disclosure

Schedule shall have been obtained and shall be in full force and effect.</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='10',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988687"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">6.5</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">No Material Adverse Change</font></b>.&#160; There shall have been no material adverse

change affecting, or that could reasonably be expected to affect, any of the

Assets or the Licensed Technology, or Restoragen&#146;s ability to consummate the

Transactions, since the date of this Agreement, and no event shall have

occurred and no condition or circumstance shall exist that could reasonably be

expected to give rise to any such material adverse change.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988688"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">6.6</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Additional Documents</font></b>.&#160; Amylin shall have received such

documents as Amylin may request in good faith for the purpose of

(i)&nbsp;evidencing the accuracy of any representation or warranty made by

Restoragen, (ii)&nbsp;evidencing the compliance by Restoragen with, or the

performance by Restoragen of, any covenant or obligation set forth in this

Agreement, (iii)&nbsp;evidencing the satisfaction of any condition set forth in

this Section&nbsp;6, or (iv)&nbsp;otherwise facilitating the consummation or

performance of any of the Transactions.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988689"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">6.7</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">No Proceedings</font></b>.&#160; Other than the Chapter&nbsp;11 Filing, since the date of this

Agreement, there shall not have been commenced or threatened against Amylin, or

against any Person affiliated with Amylin, any Proceeding (a)&nbsp;involving

any material challenge to, or seeking material damages or other material relief

in connection with, any of the Transactions, or (b)&nbsp;that may have the

effect of preventing, delaying, making illegal or otherwise interfering with

any of the Transactions.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988690"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">6.8</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">No Prohibition</font></b>.&#160; Neither the consummation nor the performance of any the

Transactions will, directly or indirectly (with or without notice or lapse of

time), contravene or conflict with or result in a violation of, or cause Amylin

or any Person affiliated with Amylin to suffer any adverse consequence under,

any applicable Legal Requirement or Order.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:left;text-indent:-.5in;"><a name="_Toc22988694"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">7.</font></b></a><font size="1" style="font-size:3.0pt;text-transform:uppercase;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;text-transform:uppercase;">Conditions Precedent to

Restoragen&#146;s Obligation to Close.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Restoragen&#146;s obligation to sell the Assets and to take

the other actions required to be taken by Restoragen at the Closing is subject

to the satisfaction, at or prior to the Closing, of each of the following

conditions (any of which may be waived by Restoragen, in whole or in part, in

writing):</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988695"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">7.1</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Bankruptcy

Court Approval</font></b>.&#160; The Bankruptcy Court shall have entered the

Approval Order.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">7.2</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Accuracy Of Representations</font></b>.&#160; All of the representations and warranties

made by Amylin in this Agreement (considered collectively), and each of said

representations and warranties (considered individually), shall have been

accurate in all material respects as of the date of this Agreement and shall be

accurate in all material respects as of the Scheduled Closing Time as if made

at the Scheduled Closing Time.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988696"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">7.3</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Purchaser&#146;s Performance.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Amylin

shall have executed the Bill of Sale and delivered it to Restoragen;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Amylin

shall have made the payment contemplated by Section&nbsp;1.7(b)(iii).</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='11',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(c)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All

of the other covenants and obligations that Amylin is required to comply with

or to perform pursuant to this Agreement at or prior to the Closing (considered

collectively), and each of said covenants and obligations (considered

individually), shall have been complied with and performed in all material

respects.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;"><a name="_Toc22988697"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">8.</font></b></a><font size="1" style="font-size:3.0pt;text-transform:uppercase;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;text-transform:uppercase;">Development Program</font></b>.&#160; This Section&nbsp;8 shall become effective only upon the Closing:</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">8.1</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Completion

of Ongoing Study</font></b>.&#160; Commencing on the Closing Date, Restoragen

shall assist Amylin in the orderly transfer of responsibility for the Study,

and the parties shall use commercially reasonable efforts to complete such

transfer of responsibility as promptly as practicable (and in any event within

fifteen (15) days) following the Closing Date.&#160;

From and after the completion of such transfer, Amylin shall be

responsible for overseeing, and shall bear the costs of, the conduct of the

Study and shall use commercially reasonable efforts to complete, or cause to be

completed, the Study and the Study Report.&#160;

The parties acknowledge that as of the Effective Date, Amylin intends to

enter into consulting arrangements with Drs. David Hathaway and Roberta

Schneider to perform day-to-day management of the Study, provided that this

sentence shall not be construed as creating any binding obligation on either

party, nor shall it be construed as a condition to either party&#146;s obligation to

effect the Closing.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">8.2</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Additional

Development</font></b>.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Within

thirty (30) days of its receipt of the report of interim data from the Study,

Amylin shall have completed its analysis of such interim data contained in such

report to assess whether such data meets or exceeds the criteria set forth in <b><i><font style="font-style:italic;font-weight:bold;">Exhibit&nbsp;E</font></i></b> hereto (the <i><font style="font-style:italic;">&#147;</font><b><font style="font-weight:bold;">Development

Criteria</font></b>&#148;</i>) and

notified Restoragen of its conclusions and intentions.&#160; If the interim data from the Study does not

meet or exceed the Development Criteria and Amylin decides to discontinue the

Study, then Amylin shall wind down the Study and withdraw or terminate the

regulatory filings associated with the Study at its own expense.&#160; If the interim data from the Study meets or

exceeds the Development Criteria, then Amylin shall continue to manage and pay

for the costs of the Study.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Within

thirty (30) days of its receipt of the Study Report, Amylin shall have

completed its analysis of the data contained in the Study Report (the <i><font style="font-style:italic;">&#147;</font><b><font style="font-weight:bold;">Study Data</font></b>&#148;</i>) to assess whether such data

meets or exceeds the Development Criteria and notified Restoragen of its

conclusions and intentions.&#160; Regardless

of whether the Study Data meets or exceeds the Development Criteria, if Amylin

desires to move forward with development of a Product, then within one hundred

eighty (180) days after its evaluation of the Study Data, Amylin will develop

and promptly share with Restoragen a plan (the <b><i><font style="font-style:italic;font-weight:bold;">&#147;Development Plan&#148;</font></i></b>) to develop and

commercialize one (1) or more Products for a Cardiovascular Indication covered

by the Restoragen Patent Portfolio and shall thereafter during the Payment Term

use its commercially reasonable efforts to develop and commercialize at least

one (1) Product in accordance with the Development Plan.&#160; Amylin shall be solely responsible for the

costs of all development activities undertaken by it.</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='12',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">8.3</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Grant Back of GLP-1 Product Rights.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In

the event that either (i)&nbsp;Amylin does not elect to pursue development of

the GLP&#150;1 Product within one hundred eighty (180) days after its

evaluation of the Study Data or (ii)&nbsp;the Development Plan is for an

Secondary Product for a Cardiovascular Indication covered by the Restoragen

Patent Portfolio and not for a GLP-1 Product, then, at Restoragen&#146;s written

request delivered within sixty (60) days of the expiration of such 180-day

period or receipt of the Development Plan, as applicable, Amylin shall grant

and does hereby grant to Restoragen a co-exclusive (with Amylin), worldwide,

royalty-free license, with the right to grant sublicenses to any Third Party

through multiple tiers of sublicense, under the Restoragen Patent Portfolio (but

excluding any other patent rights Controlled by Amylin) to develop, make, have

made, use, sell, offer for sale, have sold and import GLP-1 Products for any

Cardiovascular Indication covered by the Restoragen Patent Portfolio, and

Amylin shall cease to have any milestone or royalty payment obligations under

Section&nbsp;9 with respect to GLP-1 Products.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In

the event that, at any time during the Payment Term, Amylin either

(i)&nbsp;makes a decision not to develop at least one (1) GLP-1 Product but

instead to pursue development of one (1) or more Secondary Products for a

Cardiovascular Indication covered by the Restoragen Patent Portfolio, or

(ii)&nbsp;ceases substantially all activities outlined in the Development Plan

for a period of one hundred twenty (120) days, then Amylin shall provide

Restoragen with prompt written notice of such decision, whereupon Amylin shall

grant and does hereby grant to Restoragen a co-exclusive (with Amylin),

worldwide, royalty-free license, with the right to grant sublicenses to any

Third Party through multiple tiers of sublicense, under the Restoragen Patent

Portfolio (but excluding any other patent rights Controlled by Amylin) to

develop, make, have made, use, sell, offer for sale, have sold and import GLP-1

Products for any Cardiovascular Indication covered by the Restoragen Patent

Portfolio.&#160; Effective upon any co&#150;exclusive

license grant under this Section&nbsp;8.3(b), Amylin shall cease to have any

milestone or royalty payment obligations under Section&nbsp;9 with respect to

GLP-1 Products for Cardiovascular Indications and shall cease to have the right

to grant licenses or sublicenses to Third Parties with respect to the

development and/or commercialization of GLP&#150;1 Products for Cardiovascular

Indications.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In

the event that Amylin grants to Restoragen a co-exclusive license under either

subsection&nbsp;(a) or subsection&nbsp;(b) of this Section&nbsp;8.3, Amylin

shall provide Restoragen with access to and the right to reference and copy all

data and regulatory information included in the Assets that is necessary or

useful for development of GLP&#150;1 Products.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">8.4</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Progress Reports; Notice of Significant Events.</font></b>&#160; During the Payment Term unless and until the

earlier of such time as Amylin has granted a co&#150;exclusive license to

Restoragen under Section&nbsp;8.3 or Amylin obtains Regulatory Approval of a

GLP&#150;1 Product in the U.S., Amylin shall:</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>on

an annual basis, provide Restoragen with written reports summarizing:</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(i)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the

status and results of its development activities with respect to GLP&#150;1

Products under the Development Plan; and</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='13',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(ii)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the

status and results of its filing, prosecution and maintenance activities with

respect to the Restoragen Patent Portfolio; and</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>provide

Restoragen with prompt written notice of significant events affecting, or that

could reasonably be expected to affect (whether in a positive or negative

manner), the development, Regulatory Approval and/or commercialization of GLP-1

Products.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">9.</font></b><font size="1" style="font-size:3.0pt;text-transform:uppercase;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;text-transform:uppercase;">Product-Related Payments</font></b><font style="text-transform:uppercase;">.</font>&#160; This Section&nbsp;9

shall become effective only upon the Closing:</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">9.1</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Milestones.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">GLP-1

Products</font></b>.&#160; Within thirty (30) days following the first

occurrence of each of the events set forth below with respect to each GLP-1

Product, Amylin shall pay to Restoragen the applicable milestone payment set

forth below:</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<table border="1" cellspacing="0" cellpadding="0" width="85%" style="border:none;border-collapse:collapse;margin-left:.4in;width:85.0%;">

 <tr>

  <td width="84%" valign="bottom" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Milestone

  Event</font></b></p>

  </td>

  <td width="2%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:2.0%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:12.98%;">

  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Milestone <br>

  Payment</font></b></p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.08%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Filing of NDA in

  the U.S. for a GLP-1 Product for an indication covered by the Restoragen

  Patent Portfolio</font></p>

  </td>

  <td width="2%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:2.0%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.32%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>

  </td>

  <td width="11%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;border-top:solid windowtext .5pt;padding:0in 0in 0in 0in;width:11.66%;">

  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,000,000</font></p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.08%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;">&nbsp;</p>

  </td>

  <td width="2%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:2.0%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.32%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="11%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:11.66%;">

  <p align="right" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.08%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Regulatory

  Approval of a GLP-1 Product in the U.S. for an indication covered by the

  Restoragen Patent Portfolio</font></p>

  </td>

  <td width="2%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:2.0%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.32%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>

  </td>

  <td width="11%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:11.66%;">

  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4,000,000</font></p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.08%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;">&nbsp;</p>

  </td>

  <td width="2%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:2.0%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.32%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="11%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:11.66%;">

  <p align="right" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.08%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Regulatory

  Approval by the European Commission to sell a GLP-1 Product in all European

  Union countries for an indication covered by the Restoragen Patent Portfolio</font></p>

  </td>

  <td width="2%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:2.0%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.32%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>

  </td>

  <td width="11%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:11.66%;">

  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,000,000</font></p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.08%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;">&nbsp;</p>

  </td>

  <td width="2%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:2.0%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.32%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="11%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:11.66%;">

  <p align="right" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.08%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Regulatory

  Approval for a GLP-1 Product in Japan for an indication covered by the

  Restoragen Patent Portfolio</font></p>

  </td>

  <td width="2%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:2.0%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.32%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>

  </td>

  <td width="11%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:11.66%;">

  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,000,000</font></p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.08%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>

  </td>

 </tr>

</table>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Each of the milestone payments described in this

Section&nbsp;9.1(a) shall be payable on a GLP-1 Product-by-GLP-1 Product basis;

<i><font style="font-style:italic;">provided, however,</font></i> that if

(i)&nbsp;a GLP-1 Product is abandoned during development after one (1) or more

of the milestone payments under this Section&nbsp;9.1(a) has been made and

(ii)&nbsp;another GLP-1 Product is developed to replace such abandoned GLP-1

Product, then only those milestone payments under this Section&nbsp;9.1(a) that

were not previously made with respect to such abandoned GLP-1 Product shall be

payable with respect to the replacement GLP-1 Product.&#160; Except as set forth in the preceding

sentence, all milestone payments are non-refundable and non-creditable.</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Secondary

Products Approved for Cardiovascular Indication.</font></b>&#160; Within thirty (30) days following the first

occurrence of each of the events set forth below with respect to each Secondary

Product developed for a Cardiovascular Indication, regardless of whether such

Secondary Product has previously received Regulatory Approval for an indication

other than a Cardiovascular Indication, Amylin shall pay to Restoragen the

applicable milestone payment set forth below:</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='14',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<table border="1" cellspacing="0" cellpadding="0" width="85%" style="border:none;border-collapse:collapse;margin-left:.4in;width:85.0%;">

 <tr>

  <td width="84%" valign="bottom" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Milestone

  Event</font></b></p>

  </td>

  <td width="2%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:2.0%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:12.98%;">

  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Milestone <br>

  Payment</font></b></p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.08%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Filing of NDA in

  the U.S. for a Secondary Product for a Cardiovascular Indication</font></p>

  </td>

  <td width="2%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:2.0%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.42%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>

  </td>

  <td width="11%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;border-top:solid windowtext .5pt;padding:0in 0in 0in 0in;width:11.56%;">

  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,000,000</font></p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.08%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;">&nbsp;</p>

  </td>

  <td width="2%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:2.0%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.42%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="11%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:11.56%;">

  <p align="right" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.08%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Regulatory

  Approval for an Secondary Product in the U.S. for a Cardiovascular Indication</font></p>

  </td>

  <td width="2%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:2.0%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.42%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>

  </td>

  <td width="11%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:11.56%;">

  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4,000,000</font></p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.08%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;">&nbsp;</p>

  </td>

  <td width="2%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:2.0%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.42%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="11%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:11.56%;">

  <p align="right" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.08%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Regulatory

  Approval by the European Commission to sell an Secondary Product in all

  European Union countries for a Cardiovascular Indication</font></p>

  </td>

  <td width="2%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:2.0%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.42%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>

  </td>

  <td width="11%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:11.56%;">

  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,000,000</font></p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.08%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;">&nbsp;</p>

  </td>

  <td width="2%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:2.0%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.42%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="11%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:11.56%;">

  <p align="right" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.08%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Regulatory

  Approval for an Secondary Product in Japan for a Cardiovascular Indication</font></p>

  </td>

  <td width="2%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:2.0%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.42%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>

  </td>

  <td width="11%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:11.56%;">

  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,000,000</font></p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.08%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>

  </td>

 </tr>

</table>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Each of the milestone payments described in this

Section&nbsp;9.1(b) shall be payable on a Secondary Product-by-Secondary

Product basis; <i><font style="font-style:italic;">provided, however,</font></i>

that if (i)&nbsp;a Secondary Product is abandoned during development after one

(1) or more of the milestone payments under this Section&nbsp;9.1(b) has been

made and (ii)&nbsp;another Secondary Product is developed to replace such

abandoned Secondary Product, then only those milestone payments under this Section&nbsp;9.1(b)

that were not previously made with respect to such abandoned Secondary Product

shall be payable with respect to the replacement Secondary Product.&#160; Except as set forth in the preceding

sentence, all milestone payments are non-refundable and non-creditable.</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(c)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Secondary

Products Approved for Cardiovascular Indication But First Approved for

Non-Cardiovascular Indication</font></b>.&#160; Within thirty (30) days following the first

occurrence of each of the events set forth below with respect to each Secondary

Product that receives Regulatory Approval in the U.S. for a Cardiovascular

Indication, which Secondary Product at the time of such Regulatory Approval had

previously received Regulatory Approval in the U.S. for an indication other

than a Cardiovascular Indication, Amylin shall pay to Restoragen the applicable

milestone payment set forth below:</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='15',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<table border="1" cellspacing="0" cellpadding="0" width="85%" style="border:none;border-collapse:collapse;margin-left:.4in;width:85.0%;">

 <tr>

  <td width="84%" valign="bottom" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Milestone

  Event</font></b></p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.72%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="13%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:13.0%;">

  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Milestone <br>

  Payment</font></b></p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.06%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">First Commercial

  Sale of such Secondary Product in the U.S.</font></p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.72%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.52%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>

  </td>

  <td width="11%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;border-top:solid windowtext .5pt;padding:0in 0in 0in 0in;width:11.48%;">

  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,000,000</font></p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.06%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.72%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.52%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="11%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:11.48%;">

  <p align="right" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.06%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cumulative Net

  Sales of such Secondary Product of $250,000,000</font></p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.72%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.52%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>

  </td>

  <td width="11%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:11.48%;">

  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,000,000</font></p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.06%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.72%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.52%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="11%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:11.48%;">

  <p align="right" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.06%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cumulative Net

  Sales of such Secondary Product of $500,000,000</font></p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.72%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.52%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>

  </td>

  <td width="11%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:11.48%;">

  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,000,000</font></p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.06%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.72%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.52%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="11%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:11.48%;">

  <p align="right" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.06%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

 </tr>

 <tr>

  <td width="84%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:84.22%;">

  <p align="left" style="margin:0in 0in .0001pt 10.0pt;text-align:left;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cumulative Net

  Sales of such Secondary Product of $1,000,000,000</font></p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.72%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:0in;">&nbsp;</p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.52%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>

  </td>

  <td width="11%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:11.48%;">

  <p align="right" style="margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,000,000</font></p>

  </td>

  <td width="1%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:1.06%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>

  </td>

 </tr>

</table>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Each of the milestone payments described in this

Section&nbsp;9.1(c) shall be payable once per Secondary Product meeting the

criteria set forth above in this Section&nbsp;9.1(c).&#160; For purposes of clarification, the foregoing milestones shall be

in addition to the milestones payable under Section&nbsp;9.1(b), but no

royalties shall be due under Section&nbsp;9.2 of this Agreement with respect to

Secondary Products meeting the criteria set forth in the first sentence of this

Section&nbsp;9.1(c).&#160; All such milestone

payments are non-refundable and non-creditable.</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">9.2</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Royalties.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">GLP-1

Product Royalties</font></b>.&#160; Amylin shall pay to Restoragen a royalty of

six percent (6%) of Net Sales of GLP-1 Products that receive Regulatory

Approval for an indication covered by the Restoragen Patent Portfolio.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Secondary

Product Royalties</font></b>.&#160; Except as otherwise set forth in

Section&nbsp;9.1(c) above, Amylin shall pay to Restoragen a royalty of:</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(i)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>one

percent (1%) of Net Sales of any Secondary Product that receives Regulatory

Approval for a Cardiovascular Indication, which Secondary Product, at the time

of such Regulatory Approval, has not received Regulatory Approval in the U.S.

for an indication other than a Cardiovascular Indication; and</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(ii)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>one

percent (1%) of Net Sales of any Secondary Product that receives Regulatory

Approval in the U.S. for an indication other than a Cardiovascular Indication

(excluding any Secondary Product for which milestones are payable under

Section&nbsp;9.1(c)).</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For purposes of clarification, a given Product shall

be subject to only one royalty payment under this Section&nbsp;9.2 <i><font style="font-style:italic;">(i.e.</font></i>, Section&nbsp;9.2(a), 9.2(b)(i) or

9.2(b)(ii)), and no royalties shall be due hereunder with respect to any

product that is not either (x)&nbsp;a GLP-1 Product or (y)&nbsp;an Secondary

Product meeting the criteria set forth in Section&nbsp;9.2(b)(i) or

9.2(b)(ii).&#160; Royalties under this

Section&nbsp;9.2 shall be payable on a Product-by-Product and

country-by-country basis until the later of (i)&nbsp;expiration of the last to

expire of the issued patents within the Restoragen Patent Portfolio containing

a Valid Claim covering the manufacture, use or sale of such Product in such

country</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='16',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">and (ii)&nbsp;ten (10) years after the First

Commercial Sale of the Product in such country (the <i><font style="font-style:italic;">&#147;</font><b><font style="font-weight:bold;">Royalty Term</font></b>&#148;</i>).</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(c)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Third Party

Royalties.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(i)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If,

following the Closing, Amylin enters into any Contract that would obligate

Amylin to pay any royalty to a Third Party with respect to the manufacture, use

or sale of a Product by Amylin, its Affiliates, licensees and/or sublicensees,

Amylin shall be solely responsible for the payment of such royalties and shall

not be entitled to deduct any portion of such royalties from any payments due

to Restoragen hereunder.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(ii)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If

Amylin is required to pay any royalty to a Third Party pursuant to any Acquired

Contract that is a letter agreement between Restoragen and one or more

inventors with respect to the manufacture, use or sale of a Product by Amylin,

its Affiliates and/or sublicensees, Amylin shall be entitled to deduct all

royalties actually paid by Amylin under such Acquired Contract(s) from the

royalty payments that would otherwise be payable to Restoragen by Amylin

hereunder with respect to such Product; <i><font style="font-style:italic;">provided, however</font></i>, that in no event shall

the royalty payable to Restoragen hereunder be reduced to less than zero (0) by

operation of this Section&nbsp;9.2(c)(ii) (<i><font style="font-style:italic;">i.e.</font></i>,

in no event shall royalties under any Acquired Contract be payable by

Restoragen to Amylin or the applicable Third Party).</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">9.3</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Calculation

and Payment of Royalties</font></b>.&#160; Payments pursuant to Section&nbsp;9.2 and

reports for the sale of Products shall be calculated and reported for each

calendar quarter.&#160; All payments due to

Restoragen<font style="text-transform:uppercase;">  </font>pursuant to

Section&nbsp;9.2 shall be paid within seventy-five (75) days of the end of each

calendar quarter, unless otherwise specifically provided herein.&#160; Each such payment shall be accompanied by a

report of Net Sales of Products in sufficient detail to permit confirmation of

the accuracy of the payment made, including, without limitation, the number of

Products sold, the gross sales and Net Sales of Products, an accounting of all

deductions taken in the calculation of Net Sales, a separate accounting for all

combination Products sold and the formulas used in the calculation of the

royalty owed thereon, the royalty payable under Section&nbsp;9.2, in U.S.

dollars, the method used to calculate such royalty and the exchange rates used.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">9.4</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Tax

Withholding</font></b>.&#160; Restoragen will pay any and all taxes

levied on account of any license fee, royalty or milestone payments received by

it under this Agreement.&#160; If any taxes

are required to be withheld by Amylin, Amylin will (a)&nbsp;deduct such taxes

from the payment made to Restoragen, (b)&nbsp;timely pay the taxes to the

proper taxing authority, and (c)&nbsp;send proof of payment to Restoragen and

certify its receipt by the taxing authority within thirty (30) days following

such payment.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">9.5</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Exchange

Rate; Manner and Place of Payment</font></b>.&#160; All payments hereunder

shall be payable in U.S. dollars.&#160; With

respect to each quarter, for countries other than the United States, whenever

conversion of payments from any foreign currency shall be required, such

conversion shall be made at the rate of exchange reported in <i><font style="font-style:italic;">The Wall

Street Journal, Western Edition</font></i>, on the last business day of the

applicable quarter.&#160; All payments owed

under this Agreement shall be made by wire transfer to a bank and account

designated in writing by Restoragen, unless otherwise specified in writing by

Restoragen.</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='17',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">9.6</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Prohibited Payments</font></b>. Notwithstanding any

other provision of this Agreement, if Amylin is prevented from paying any such

royalty by virtue of the statutes, laws, codes or governmental regulations of

the country from which the payment is to be made, then such royalty may be paid

by depositing funds in the currency in which accrued to Restoragen&#146;s account in

a bank acceptable to Restoragen in the country whose currency is involved.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">9.7</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Records;

Audits</font></b>.&#160; During the Payment Term and for a period of

four (4) years thereafter, Amylin shall keep complete and accurate records

pertaining to the sale or other disposition of Products in sufficient detail to

permit Restoragen to confirm the accuracy of payments due hereunder.&#160; Restoragen shall have the right to cause an

independent, certified public accountant reasonably acceptable to Amylin to

audit such records to confirm Net Sales and royalty payments for a period

covering not more than the preceding four (4) years.&#160; Restoragen agrees to treat, and to use its best efforts to cause

such accountant to treat, all such information as confidential and not to use

or disclose any such information for any purpose except to determine compliance

with this Agreement.&#160; For the avoidance

of doubt, Amylin shall not be obligated to provide Restoragen or such

accountant with access to any records or information other than that which is

necessary to confirm Net Sales and royalty payments hereunder.&#160; Such audits may be exercised during normal

business hours upon reasonable prior written notice to Amylin.&#160; Books and records for a given calendar year

may only be audited once.&#160; Prompt

adjustments shall be made by the parties to reflect the results of such

audit.&#160; Restoragen shall bear the full

cost of such audit unless such audit discloses a variance of more than ten

percent (10%) from the amount of Net Sales or royalties due under this

Agreement, in which case, Amylin shall bear the full cost of such audit.&#160; Amylin shall either (i) keep for at least

four (4) years copies of records of its Affiliates and sublicensees sufficient

for auditing purposes under this Section 9.7 or (ii) secure the right for

Restoragen to conduct an audit of the records of Amylin&#146;s Affiliates and

sublicensees under this Section 9.7 including records pertaining to gross sales

of Products and all deductions taken in the calculation of Net Sales.&#160; This Section 9.7 shall survive any

termination of this Agreement for five (5) years.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">10.</font></b><font size="1" style="font-size:3.0pt;text-transform:uppercase;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;text-transform:uppercase;">Patent Rights</font></b><font style="text-transform:uppercase;">.</font>&#160; This Section&nbsp;10 shall become effective

only upon the Closing:</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">10.1</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Patent Prosecution and Maintenance.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Restoragen Patent Portfolio</font></b>.&#160;

Amylin shall have the first right, but not the obligation, to file,

prosecute and maintain all patent applications and patents included in the

Restoragen Patent Portfolio.&#160; Amylin

shall provide Restoragen with an opportunity to review and discuss with Amylin

prosecution strategy and to consult with Amylin on the content of such patent

filings, and Amylin shall consider in good faith Restoragen&#146;s reasonable

suggestions regarding such patent filings.&#160;

Notwithstanding the foregoing, Amylin shall have sole and final

decision-making authority with respect to the prosecution and maintenance of

the Restoragen Patent Portfolio.&#160; Amylin

shall be responsible for all costs, fees and expenses incurred from and after

the Closing in connection with the filing, prosecution and maintenance of the

patent applications and patents included in the Restoragen Patent

Portfolio.&#160; Amylin agrees to notify Restoragen

in writing in a timely manner (and in any event not fewer than thirty (30) days

before any office action or other applicable governmental deadline) if it

decides not to continue the prosecution or appeals or maintenance of any of the

patent applications and patents included in the Restoragen Patent

Portfolio.&#160; In the event Amylin does not

continue the filing, prosecution or</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='18',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">maintenance of any patent

application or patent included in the Restoragen Patent Portfolio, Amylin

shall, at Restoragen&#146;s written request given within thirty (30) days after the

applicable notice from Amylin, assign such patent application or patent to

Restoragen (subject, in any event, to Amylin&#146;s obligations to any inventor(s)

named in such patent application or patent under the Acquired Contracts, if

applicable).</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Manufacturing Patents</font></b>.&#160;

Restoragen shall have the first right, but not the obligation, to file,

prosecute and maintain all patent applications and patents included in the

Manufacturing Patents.&#160; Restoragen shall

provide Amylin with an opportunity to review and discuss with Restoragen

prosecution strategy and to consult with Restoragen on the content of such

patent filings, and Restoragen shall consider in good faith Amylin&#146;s reasonable

suggestions regarding such patent filings.&#160;

Restoragen shall be responsible for all costs, fees and expenses

incurred from and after the Closing in connection with the filing, prosecution

and maintenance of the patent applications and patents included in the

Manufacturing Patents.&#160; Restoragen

agrees to notify Amylin in writing in a timely manner if it does not desire to

support the continued prosecution or appeals or maintenance of any of the

patent applications and patents included in the Manufacturing Patents.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">10.2</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Patent Enforcement</font></b>.&#160; Each party shall promptly notify the other

in writing of any alleged or threatened infringement of any Licensed Patent of

which such party becomes aware.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Restoragen

Patent Portfolio</font></b>.&#160; With respect to any infringement of any

patent included in the Restoragen Patent Portfolio, Amylin shall have the first

right, but not the obligation, to bring and control any action or proceeding

with respect to such infringement at its own expense and by counsel of its own

choice, and Restoragen shall have the right, at its own expense, to be

represented in any such action by counsel of its own choice.&#160; If Amylin fails to bring an action or

proceeding within (A)&nbsp;sixty (60) days following the notice of alleged

infringement or (B)&nbsp;ten (10) days before the time limit, if any, set forth

in the applicable laws and regulations for the filing of such actions,

whichever comes first, Restoragen shall have the right to bring and control any

action or proceeding with respect to such infringement at its own expense and

by counsel of its own choice, and Amylin shall have the right, at its own

expense, to be represented in any such action by counsel of its own choice.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Manufacturing

Patents</font></b>.&#160; With respect to any infringement of any

patent included in the Manufacturing Patents, Restoragen shall have the first

right, but not the obligation, to bring and control any action or proceeding

with respect to such infringement at its own expense and by counsel of its own

choice, and Amylin shall have the right, at its own expense, to be represented

in any such action by counsel of its own choice.&#160; If Restoragen fails to bring an action or proceeding within

(A)&nbsp;sixty (60) days following the notice of alleged infringement or (B)&nbsp;ten

(10) days before the time limit, if any, set forth in the applicable laws and

regulations for the filing of such actions, whichever comes first, Amylin shall

have the right to bring and control any action or proceeding with respect to

such infringement at its own expense and by counsel of its own choice, and

Restoragen shall have the right, at its own expense, to be represented in any

such action by counsel of its own choice.</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='19',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(c)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Generally</font></b>.&#160;

In the event a party brings an infringement action in accordance with

this Section&nbsp;10.2, the other party shall cooperate fully, including if

required to bring such action, the furnishing of a power of attorney.&#160; Neither party shall have the right to settle

any patent infringement litigation under this Section&nbsp;10.2 in a manner

that diminishes the rights or interests of the other party without the consent

of such other party (which shall not be unreasonably withheld).&#160; Except as otherwise agreed to by the parties

as part of a cost-sharing arrangement, any recovery realized as a result of

such litigation, after reimbursement of any litigation expenses of Amylin and

Restoragen, shall be retained by the party that brought and controlled such

litigation for purposes of this Agreement, except that any recovery realized by

Amylin as a result of such litigation, after reimbursement of the parties&#146;

litigation expenses, shall, to the extent attributable to lost sales of

Products, be treated as Net Sales of Products by Amylin.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">10.3</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Third Party Infringement Claims</font></b>.&#160; Each party shall promptly notify the other

in writing of any allegation by a Third Party that the activity of either of

the parties pursuant to this Agreement infringes or may infringe the

Intellectual Property Rights of such Third Party.&#160; A party shall have the sole right to control any defense of any

such claim involving alleged infringement of Third Party rights by such party&#146;s

activities at its own expense and by counsel of its own choice.&#160; Neither party shall have the right to settle

any patent infringement litigation under this Section&nbsp;10.3 in a manner

that diminishes the rights or interests of the other party without the consent

of such other party (which shall not be unreasonably withheld).</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:left;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">11.</font></b><font size="1" style="font-size:3.0pt;text-transform:uppercase;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;text-transform:uppercase;">Confidentiality</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">11.1</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Confidentiality</font></b>.&#160;

Except to the extent expressly authorized by this Agreement or otherwise

agreed in writing by the parties, the parties agree that, for so long as this

Agreement is in effect, and for a period of five (5) years thereafter, each

party (the <i><font style="font-style:italic;">&#147;</font><b><font style="font-weight:bold;">Receiving

Party</font></b>&#148;</i>) will

maintain in confidence all Confidential Information disclosed by the other

before or after the date of this Agreement (the <i><font style="font-style:italic;">&#147;</font><b><font style="font-weight:bold;">Disclosing Party</font></b>&#148;</i>).&#160; The parties hereby

agree that all information exchanged by the parties prior to the date of this

Agreement under that certain Confidentiality Agreement dated March&nbsp;6, 2002

between the parties (the <b><i><font style="font-style:italic;font-weight:bold;">&#147;Confidentiality

Agreement&#148;</font></i></b>) shall be subject to the terms and conditions of this

Section&nbsp;11.&#160; The Receiving Party

may use the Confidential Information of the Disclosing Party only to the extent

required to accomplish the purposes of this Agreement.&#160; The Receiving Party shall use at least the

same standard of care as it uses to protect proprietary or confidential

information of its own to ensure that its employees, agents, consultants and

other representatives do not disclose or make any unauthorized use of the

Disclosing Party&#146;s Confidential Information.&#160;

Each party will promptly notify the other upon discovery of any

unauthorized use or disclosure of the other party&#146;s Confidential Information.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">11.2</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Exceptions</font></b>.&#160; The

obligations of confidentiality contained in Section&nbsp;11.1 will not apply to

the extent that it can be established by the Receiving Party by competent proof

that such Confidential Information: (a)&nbsp;was already known to the Receiving

Party, other than under an obligation of confidentiality, at the time of

disclosure by the Disclosing Party; (b)&nbsp;was generally available to the

public or otherwise part of the public domain at the time of its disclosure to

the Receiving Party; (c)&nbsp;became generally available to the public or

otherwise part of the public domain after its disclosure and other than through

any act or omission of the Receiving Party in breach of this Agreement; or

(d)&nbsp;was disclosed to the Receiving Party, other than under an </p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">20</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='20',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">obligation of confidentiality, by a Third Party who

had no obligation to the Disclosing Party not to disclose such informa&#173;tion to

others.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">11.3</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Authorized

Disclosure</font></b>.&#160; Each party may disclose the Confidential

Information to the extent such disclosure is reasonably necessary in the

following instances:&#160; (a)&nbsp;filing,

prosecuting or maintaining the Restoragen Patent Portfolio or the Manufacturing

Patents in accordance with this Agreement; (b)&nbsp;in the case of Amylin,

practicing the inventions claimed in the Restoragen Patent Portfolio,

practicing the License granted hereunder or preparing and submitting regulatory

filings with respect to Products; (c)&nbsp;prosecuting or defending litigation

or complying with applicable court orders or governmental regulations; or

(d)&nbsp;disclosure to Affiliates, sublicensees, employees, consultants, agents

or other Third Parties in connection with due diligence or similar

investigations by such Third Parties, and disclosure to potential Third Party

investors in confidential financing documents, provided, in each case, that any

such Affiliate, sublicensee, employee, consultant, agent or Third Party agrees

to be bound by similar terms of confidentiality and non-use at least equivalent

in scope to those set forth in this Section&nbsp;6.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding the

foregoing, in the event a party is required to make a disclosure of the other

party&#146;s Confidential Information pursuant to Section&nbsp;11.3(c), it will,

except where impracticable, give reasonable advance notice to the other party

of such disclosure and use efforts to secure confidential treatment of such

information at least as diligent as such party would use to protect its own

confidential information, but in no event less than reasonable efforts.</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:left;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">12.</font></b><font size="1" style="font-size:3.0pt;text-transform:uppercase;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;text-transform:uppercase;">Termination Prior to Closing.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988698"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">12.1</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Termination Events</font></b>.&#160; This Agreement may be terminated prior to

the Closing:</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by

Amylin if (i)&nbsp;there is a material Breach of any covenant or obligation of

Restoragen and such Breach shall not have been cured within thirty days after

the delivery of notice thereof to Restoragen, or (ii)&nbsp;Amylin reasonably

determines that the timely satisfaction of any condition set forth in

Section&nbsp;6 has become impossible or impractical (other than as a result of

any failure on the part of Amylin to comply with or perform its covenants and

obligations set forth in this Agreement);</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by

Restoragen if (i)&nbsp;there is a material Breach of any covenant or obligation

of Amylin and such Breach shall not have been cured within thirty days after

the delivery of notice thereof to Amylin, or (ii)&nbsp;Restoragen reasonably

determines that the timely satisfaction of any condition set forth in

Section&nbsp;7 has become impossible or impractical (other than as a result of

any failure on the part of Restoragen to comply with or perform any covenant or

obligation set forth in this Agreement);</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(c)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by

Amylin at or after the Scheduled Closing Time if any condition set forth in

Section&nbsp;6 has not been satisfied by the Scheduled Closing Time;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(d)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by

Restoragen at or after the Scheduled Closing Time if any condition set forth in

Section&nbsp;7 has not been satisfied by the Scheduled Closing Time;</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='21',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(e)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by

Amylin if the Closing has not taken place on or before March&nbsp;15, 2003

(other than as a result of any failure on the part of Amylin to comply with or

perform its covenants and obligations under this Agreement);</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(f)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by

Restoragen if the Closing has not taken place on or before March&nbsp;15, 2003

(other than as a result of any failure on the part of Restoragen to comply with

or perform any covenant or obligation set forth in this Agreement); or</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(g)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by

the mutual written consent of Amylin and Restoragen.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988699"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">12.2</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Termination Procedures</font></b>.&#160; If Amylin wishes to terminate this Agreement

pursuant to Section&nbsp;12.1(a), Section&nbsp;12.1(c), Section&nbsp;12.1(e) or

Section&nbsp;12.1(g), Amylin shall deliver to Restoragen a written notice

stating that Amylin is terminating this Agreement and setting forth a brief

description of the basis on which Amylin is terminating this Agreement.&#160; If Restoragen wishes to terminate this

Agreement pursuant to Section&nbsp;12.1(b), Section&nbsp;12.1(d) or

Section&nbsp;12.1(f), Restoragen shall deliver to Amylin a written notice stating

that Restoragen is terminating this Agreement and setting forth a brief

description of the basis on which Restoragen is terminating this Agreement.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988700"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">12.3</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Effect Of Termination</font></b>.&#160; If this Agreement is terminated pursuant to

Section&nbsp;12.1, all further obligations of the parties under this Agreement

shall terminate; <i><font style="font-style:italic;">provided, however</font></i>, that, except as otherwise provided

herein:&#160; (a) no party shall be relieved

of any obligation or other Liability arising from any Breach by such party of

any provision of this Agreement; and (b) the parties shall, in all events, remain

bound by and continue to be subject to the provisions set forth in

Sections&nbsp;11 and 16.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988701"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">12.4</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Nonexclusivity Of Termination Rights</font></b>.&#160; The termination rights provided in

Section&nbsp;12.1 shall not be deemed to be exclusive.&#160; Accordingly, the exercise by any party of

its right to terminate this Agreement pursuant to Section&nbsp;12.1 shall not

be deemed to be an election of remedies and shall not be deemed to prejudice,

or to constitute or operate as a waiver of, any other right or remedy that such

party may be entitled to exercise (whether under this Agreement, under any

other Contract, under any statute, rule or other Legal Requirement, at common

law, in equity or otherwise).</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;"><a name="_Toc22988702"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">13.</font></b></a><font size="1" style="font-size:3.0pt;text-transform:uppercase;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;text-transform:uppercase;">Payment Term; Termination of Payment Term</font></b><font style="text-transform:uppercase;">.</font>&#160; This Section&nbsp;13 shall become effective only

upon the Closing.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">13.1</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Term</font></b>.&#160;

The term of the License (the <i><font style="font-style:italic;">&#147;</font><b><font style="font-weight:bold;">Payment Term</font></b>&#148;</i>) will commence as of the Closing and, unless sooner

terminated as provided hereunder, will terminate upon the expiration of the

last Royalty Term.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">13.2</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Termination

for Cause</font></b>. &#160;Each party shall have the right to terminate

the License upon sixty (60) days&#146; written notice to the other upon or after the

Breach of any material provision of this Agreement by the other party if the

breaching party has not cured such Breach within the sixty (60) day period

following written notice of termination by the non-breaching party.</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='22',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">13.3</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Effect of Termination; Surviving Obligations.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Upon

termination of the License pursuant to Section&nbsp;13.2 by Amylin:

(i)&nbsp;the License granted by Restoragen to Amylin in Section&nbsp;1.2 shall

terminate and revert to Restoragen; and (ii)&nbsp;all other rights <font style="letter-spacing:-.15pt;">and</font> obligations of the parties under this

Agreement shall terminate, except as set forth in this Section&nbsp;13.3.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Upon

termination of the License pursuant to Section&nbsp;13.2 by Restoragen:

(i)&nbsp;the License granted by Restoragen to Amylin in Section&nbsp;1.2 shall

terminate and <a name="_Toc14247286">revert to Restoragen;</a> (ii)&nbsp;any

existing sublicenses under such License granted by Amylin shall remain in

effect in accordance with their terms, with Restoragen assuming Amylin&#146;s

position as sublicensor under such agreements, but only if each sublicensee

agrees to remain liable for full compliance with this Agreement; and

(iii)&nbsp;all other rights <font style="letter-spacing:-.15pt;">and</font> obligations

of the parties under this Agreement shall terminate, except as set forth in

this Section&nbsp;13.3.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(c)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Expiration

or termination of this Agreement shall not relieve the parties of any

obligation accruing prior to such expiration or termination.&#160; Except as expressly set forth elsewhere in

this Agreement, the obligations and the rights of the parties under

Sections&nbsp;9.7, 11, 13, 14 and 16 shall survive expiration or termination of

this Agreement.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">13.4</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Rights in

Bankruptcy</font></b>.&#160; All rights and licenses granted under or

pursuant to this Agreement by Restoragen are, and will otherwise be deemed to

be, for purposes of Section&nbsp;365(n) of the U.S. Bankruptcy Code, licenses

of right to &#147;intellectual property&#148; as defined under Section&nbsp;101 of the

U.S. Bankruptcy Code.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">13.5</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Remedies</font></b>.&#160;

In the event of any breach of any provision of this Agreement, in

addition to the termination rights set forth herein, each party shall have all

other rights and remedies that may be available to it at law or equity with

respect to this Agreement.&#160;

Notwithstanding the foregoing, the use by either Party hereto of a

termination right provided for under this Agreement shall not give rise to the

payment of damages or any other form of compensation or relief to the other

Party with respect thereto.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:left;text-indent:-.5in;"><a name="_Toc22988703"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">14.</font></b></a><font size="1" style="font-size:3.0pt;text-transform:uppercase;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;text-transform:uppercase;">No Survival Of

Representations, Warranties and Pre-Closing Covenants.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The representations and warranties contained in this

Agreement or in any instrument delivered in connection herewith, and the

covenants set forth in Sections&nbsp;4 and 5, shall not survive the

Closing.&#160; The representations and

warranties contained in this Agreement or in the Closing Certificate (but, for

the avoidance of doubt, <i><u><font style="font-style:italic;">not</font></u></i>

the Bill of Sale), and the covenants and obligations set forth in Sections 4

and 5, shall serve only as conditions to the Closing and shall not survive the

Closing, and no claim based thereon may be asserted other than as a

justification for refusal to proceed with the Closing; <i><font style="font-style:italic;">provided, however,</font></i> that, subject to

receipt of the Approval Order and except to the extent prohibited by the

Bankruptcy Court or the U.S. Bankruptcy Code, a party may seek to enforce the

covenants and obligations set forth in Sections&nbsp;4 and 5 in accordance with

the second sentence of Section&nbsp;16.11 prior to the Closing.&#160; Sections&nbsp;1.2, 1.3, 1.4, 1.5, 1.6, 1.7,

8, 9, 10, 11, 13, 15 and 16 shall survive the Closing and remain in full force

and effect in accordance with their respective terms.</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='23',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:left;text-indent:-.5in;"><a name="_Toc22988710"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">15.</font></b></a><font size="1" style="font-size:3.0pt;text-transform:uppercase;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;text-transform:uppercase;">Certain Post-Closing

Covenants.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988711"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">15.1</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Development and Commercialization of GLP-1 Product.</font></b>&#160; From and after the Closing Date, Amylin

shall use its commercially reasonable efforts to develop and commercialize the

GLP&#150;1 Product; <i><font style="font-style:italic;">provided </font></i>that

the parties acknowledge and agree that the sole remedy in the event that Amylin

does not comply with this Section&nbsp;15.1 is the grant back of rights under

Section&nbsp;8.3.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">15.2</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Further Actions</font></b>.&#160; From and after the Closing Date, Restoragen shall cooperate with

Amylin and Amylin&#146;s affiliates and Representatives, and shall execute and

deliver such documents and take such other actions as Amylin may reasonably

request, for the purpose of evidencing the Transactions and putting Amylin in

possession and control of all of the Assets.&#160;

In addition, from and after the Closing Date, the parties shall

cooperate as reasonably necessary to facilitate the transfer to Amylin or its

designee of all tangible items included in the Assets.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">15.3</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Consulting

Agreements</font></b>.&#160; Restoragen hereby agrees that, subject to

the Closing and the receipt of Study Data meeting the Development Criteria,

Amylin shall have the right to enter into consulting agreements with Drs. David

Hathaway and Roberta Schneider under which such individuals will provide

services related to the Study as more fully described in the Side Letters and

on such other terms and conditions as may be set forth in such consulting

agreements.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988712"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">15.4</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Publicity</font></b>.&#160;

Each party shall ensure that, on and at all times after the Closing

Date, no press release or other publicity concerning any of the Transactions is

issued or otherwise disseminated by or on behalf of such party without the

other party&#146;s prior written consent, except as may be legally required.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">15.5</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Insurance.</font></b>&#160;

At all times from the Closing Date through August&nbsp;14, 2003,

Restoragen shall maintain Clinical Trial Liability Insurance Policy No#

03-3539829 with Lexington Insurance Company.&#160;

Restoragen shall provide Amylin with a certificate of insurance as

evidence of such insurance at or before the Closing Date.&#160; If prior to August&nbsp;14, 2003, any such

insurance is significantly reduced, restricted or terminated, Restoragen shall

immediately notify Amylin in writing</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-align:left;text-indent:-.5in;"><a name="_Toc22988714"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">16.</font></b></a><font size="1" style="font-size:3.0pt;text-transform:uppercase;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;text-transform:uppercase;">Miscellaneous Provisions.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988717"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.1</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Further Assurances</font></b>.&#160; Each party hereto shall execute and/or cause

to be delivered to each other party hereto such instruments and other

documents, and shall take such other actions, as such other party may

reasonably request (prior to, at or after the Closing) for the purpose of

carrying out or evidencing any of the Transactions.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988718"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.2</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Fees and Expenses.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Restoragen

shall bear and pay all fees, costs and expenses (including all legal fees and

expenses payable to Lindquist &amp; Vennum, PLLP and other counsel retained by

Restoragen) that have been incurred or that are in the future incurred by, on

behalf of or for the benefit of Restoragen in connection with: (i)&nbsp;the

negotiation, preparation and review of any letter of intent or similar document

relating to any of the Transactions; (ii)&nbsp;the investigation and review</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='24',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">conducted by Amylin and

its Representatives with respect to the business of Restoragen (and the

furnishing of information to Amylin and its Representatives in connection with

such investigation and review); (iii)&nbsp;the negotiation, preparation and

review of this Agreement (including the Disclosure Schedule), the other

Transactional Agreements and all bills of sale, assignments, certificates,

opinions and other instruments and documents delivered or to be delivered in

connection with the Transactions; (iv)&nbsp;the preparation and submission of

any filing or notice required to be made or given in connection with any of the

Transactions, and the obtaining of any Consent required to be obtained in

connection with any of the Transactions; and (v)&nbsp;the consummation and

performance of the Transactions.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Amylin

shall bear and pay all fees, costs and expenses (including all legal fees and

expenses payable to Cooley Godward <font style="text-transform:uppercase;">llp </font>and

other counsel retained by Amylin<font style="text-transform:uppercase;">)</font>

that have been incurred or that are in the future incurred by or on behalf of

Amylin in connection with: (i)&nbsp;the negotiation, preparation and review of

any letter of intent or similar document relating to any of the Transactions;

(ii)&nbsp;the investigation and review conducted by Amylin and its

Representatives with respect to the business of Restoragen; (iii)&nbsp;the

negotiation, preparation and review of this Agreement, the other Transactional

Agreements and all bills of sale, assignments, certificates, opinions and other

instruments and documents delivered or to be delivered in connection with the

Transactions; (iv)&nbsp;the preparation and submission of any filing or notice

required to be made or given in connection with any of the Transactions; and

(v)&nbsp;the consummation and performance of the Transactions.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988720"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.3</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Notices</font></b>.&#160;

Any notice or other communication required or permitted to be delivered

to any party under this Agreement shall be in writing and shall be deemed

properly delivered, given and received when delivered (by hand, by registered

mail, by courier or express delivery service or by facsimile) to the address or

facsimile telephone number set forth beneath the name of such party below (or

to such other address or facsimile telephone number as such party shall have

specified in a written notice given to the other parties hereto):</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988721"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If to Amylin, notices must be addressed to:</font></a></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amylin Pharmaceuticals,

Inc.</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9373 Towne Centre Drive</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">San Diego, CA&#160; 92121</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attention: President and

Chief Executive Officer</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Telephone: (858) 552-2200</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Facsimile: (858) 552-1936</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">with a copy to:</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amylin Pharmaceuticals,

Inc.</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9373 Towne Centre Drive</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">San Diego, CA&#160; 92121</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attention: General

Counsel</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Telephone: (858) 552-2200</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Facsimile: (858) 552-1936</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='25',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">and a copy to:</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cooley Godward <font style="text-transform:uppercase;">llp</font></font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4401 Eastgate Mall</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">San Diego, CA&#160; 92121</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attention: Thomas A.

Coll, Esq.</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Telephone: (858) 550-6000</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Facsimile: (858) 550-6420</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If to Restoragen, notices

must be addressed to:</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Restoragen, Inc.</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3820 NW 46<sup>th</sup>

Street</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Lincoln, NE&#160; 68524</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attention: Chief Executive

Officer</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Telephone: 402-470-2100</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Facsimile: 402-470-2345</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">with a copy to:</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Lindquist &amp; Vennum,

PLLP</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4200 IDS Center</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">80 South Eighth Street</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Minneapolis, MN 55402</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attention:&#160; Barbara Lano Rummel</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Telephone: 612-371-3940</font></p>



<p align="left" style="margin:0in 0in .0001pt 1.5in;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Facsimile: 612-371-3207</font></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.4</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Time Of The Essence</font></b>.&#160; Time is of the essence of this Agreement.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988722"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.5</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Headings</font></b>.&#160;

The underlined headings contained in this Agreement are for convenience

of reference only, shall not be deemed to be a part of this Agreement and shall

not be referred to in connection with the construction or interpretation of

this Agreement.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988723"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.6</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Counterparts</font></b>.&#160; This Agreement may be executed in several counterparts, each of

which shall constitute an original and all of which, when taken together, shall

constitute one agreement.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988724"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.7</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Governing Law</font></b>.&#160; This Agreement shall be governed by, and

construed and enforced in accordance with, the laws of the State of Delaware,

excluding its conflicts of laws principles.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988725"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.8</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Limitation of Liability</font></b>.&#160;

NEITHER PARTY SHALL BE ENTITLED TO RECOVER FROM THE OTHER PARTY ANY

SPECIAL, INCIDENTAL, INDIRECT, CONSEQUENTIAL OR PUNITIVE DAMAGES IN CONNECTION

WITH THIS AGREEMENT OR ANY LICENSE GRANTED HEREUNDER.</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">26</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='26',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.9</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Successors And Assigns; Parties In Interest.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This

Agreement shall be binding upon:&#160;

Restoragen and its successors and assigns (if any); and Amylin and its

successors and assigns (if any).&#160; This

Agreement shall inure to the benefit of:&#160;

Restoragen; Amylin; and the respective successors and assigns (if any)

of the foregoing.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Amylin

may freely assign any or all of its rights under this Agreement, in whole or in

part, to any other Person without obtaining the consent or approval of

Restoragen.&#160; During the Pre&#150;Closing

Period and thereafter until such time as the transfer of the Assets to Amylin

is complete, Restoragen shall not be permitted to assign any of its rights or

delegate any of its obligations under this Agreement without Amylin&#146;s prior

written consent, but thereafter Restoragen may freely assign any or all of its

rights under this Agreement, in whole or in part, to any other Person without

obtaining the consent or approval of Amylin.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(c)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>None

of the provisions of this Agreement is intended to provide any rights or

remedies to any Person other than the parties to this Agreement and their

respective successors and assigns (if any).&#160;

Without limiting the generality of the foregoing, (i) no employee of

Restoragen shall have any rights under this Agreement or under any of the other

Transactional Agreements, and (ii) no creditor of Restoragen shall have any

rights under this Agreement or any of the other Transactional Agreements.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988727"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.10</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Waiver.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No

failure on the part of any Person to exercise any power, right, privilege or

remedy under this Agreement, and no delay on the part of any Person in

exercising any power, right, privilege or remedy under this Agreement, shall

operate as a waiver of such power, right, privilege or remedy; and no single or

partial exercise of any such power, right, privilege or remedy shall preclude

any other or further exercise thereof or of any other power, right, privilege

or remedy.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No

Person shall be deemed to have waived any claim arising out of this Agreement,

or any power, right, privilege or remedy under this Agreement, unless the

waiver of such claim, power, right, privilege or remedy is expressly set forth

in a written instrument duly executed and delivered on behalf of such Person;

and any such waiver shall not be applicable or have any effect except in the

specific instance in which it is given.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988728"></a><a name="_Toc22988726"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.11</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Remedies

Cumulative; Specific Performance.</font></b>&#160;

The rights and remedies of the parties hereto shall be cumulative (and

not alternative).&#160; Each party agrees

that, except to the extent prohibited by the Bankruptcy Court or the U.S.

Bankruptcy Code: (a) in the event of any Breach or threatened Breach by such

party of any covenant, obligation or other provision set forth in this

Agreement, the other party shall be entitled (in addition to any other remedy

that may be available to it) to (i)&nbsp;a decree or order of specific

performance or mandamus to enforce the observance and performance of such

covenant, obligation or other provision, and (ii)&nbsp;an injunction

restraining such Breach or threatened Breach; and (b) the non&#150;breaching

party shall not be required to provide any bond or other security in connection

with any such decree, order or injunction or in connection with any related

action or Proceeding.</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">27</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='27',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.12</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Amendments</font></b>.&#160; This Agreement may not be amended, modified, altered or

supplemented other than by means of a written instrument duly executed and

delivered on behalf of Amylin and Restoragen.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988729"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.13</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Severability</font></b>.&#160; In the event that any provision of this Agreement, or the

application of any such provision to any Person or set of circumstances, shall

be determined to be invalid, unlawful, void or unenforceable to any extent, the

remainder of this Agreement, and the application of such provision to Persons or

circumstances other than those as to which it is determined to be invalid,

unlawful, void or unenforceable, shall not be impaired or otherwise affected

and shall continue to be valid and enforceable to the fullest extent permitted

by law.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988730"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.14</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Entire Agreement</font></b>.&#160; The Transactional Agreements set forth the entire understanding

of the parties relating to the subject matter thereof and supersede all prior

agreements and understandings among or between any of the parties relating to

the subject matter thereof, including, without limitation, the Confidentiality

Agreement; <i><font style="font-style:italic;">provided, however,</font></i>

that all information disclosed by either party to the other pursuant to the

Confidentiality Agreement shall be subject to the provisions of Section&nbsp;11

of this Agreement.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988731"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.15</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Knowledge</font></b>.&#160;

For purposes of this Agreement, &#147;knowledge&#148; of Restoragen of a

particular fact or other matter means actual knowledge of such fact or other

matter by the current Chief Executive Officer, Chief Financial Officer, Vice

President, Cardiovascular Strategy and/or Vice President, Clinical Development

of Restoragen after reasonable inquiry of the former Chief Scientific Officer.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><a name="_Toc22988732"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.16</font></b></a><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font style="font-weight:bold;">Construction.</font></b></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>For

purposes of this Agreement, whenever the context requires:&#160; the singular number shall include the

plural, and vice versa; the masculine gender shall include the feminine and

neuter genders; the feminine gender shall include the masculine and neuter

genders; and the neuter gender shall include the masculine and feminine

genders.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(b)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The

parties hereto agree that any rule of construction to the effect that

ambiguities are to be resolved against the drafting party shall not be applied

in the construction or interpretation of this Agreement.</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(c)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>As

used in this Agreement, the words &#147;include&#148; and &#147;including,&#148; and variations

thereof, shall not be deemed to be terms of limitation, but rather shall be

deemed to be followed by the words &#147;without limitation.&#148;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(d)</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except

as otherwise indicated, all references in this Agreement to &#147;Sections&#148; and

&#147;Exhibits&#148; are intended to refer to Sections of this Agreement and Exhibits to

this Agreement.</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='28',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">In Witness

Whereof</font></b>, the parties hereto have duly executed this

Agreement, including the Exhibits attached hereto and incorporated herein by

reference.</p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">

 <tr>

  <td width="59%" colspan="5" valign="top" style="padding:0in 0in 0in 0in;width:59.1%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">Restoragen,

  Inc.</font></b></p>

  </td>

  <td width="40%" colspan="5" valign="top" style="padding:0in 0in 0in 0in;width:40.9%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">Amylin

  Pharmaceuticals, Inc.</font></b></p>

  </td>

 </tr>

 <tr>

  <td width="59%" colspan="5" valign="top" style="padding:0in 0in 0in 0in;width:59.1%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;">&nbsp;</p>

  </td>

  <td width="6%" colspan="4" valign="top" style="padding:0in 0in 0in 0in;width:6.04%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;">&nbsp;</p>

  </td>

  <td width="34%" valign="top" style="padding:0in 0in 0in 0in;width:34.86%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;">&nbsp;</p>

  </td>

 </tr>

 <tr>

  <td width="59%" colspan="5" valign="top" style="padding:0in 0in 0in 0in;width:59.1%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;">&nbsp;</p>

  </td>

  <td width="6%" colspan="4" valign="top" style="padding:0in 0in 0in 0in;width:6.04%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;">&nbsp;</p>

  </td>

  <td width="34%" valign="top" style="padding:0in 0in 0in 0in;width:34.86%;">

  <p align="left" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:left;">&nbsp;</p>

  </td>

 </tr>

 <tr>

  <td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.84%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>

  </td>

  <td width="34%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:34.4%;">

  <p align="left" style="margin:0in 0in .0001pt 20.0pt;text-align:left;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ ASHLEIGH W. PALMER</font></p>

  </td>

  <td width="21%" valign="top" style="padding:0in 0in 0in 0in;width:21.86%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;">&nbsp;</p>

  </td>

  <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.14%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>

  </td>

  <td width="2%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:2.9%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;">&nbsp;</p>

  </td>

  <td width="34%" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:34.86%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ LLOYD

  ROWLAND</font></p>

  </td>

 </tr>

 <tr>

  <td width="5%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:5.24%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>

  </td>

  <td width="32%" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:32.0%;">

  <p align="left" style="margin:0in 0in .0001pt 17.3pt;text-align:left;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ashleigh W. Palmer</font></p>

  </td>

  <td width="21%" valign="top" style="padding:0in 0in 0in 0in;width:21.86%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;">&nbsp;</p>

  </td>

  <td width="5%" colspan="3" valign="top" style="border:none;border-top:solid windowtext .5pt;padding:0in 0in 0in 0in;width:5.52%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>

  </td>

  <td width="0%" valign="top" style="border-bottom:solid windowtext .5pt;border-left:none;border-right:none;border-top:solid windowtext .5pt;padding:0in 0in 0in 0in;width:.52%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;">&nbsp;</p>

  </td>

  <td width="34%" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:34.86%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Lloyd Rowland</font></p>

  </td>

 </tr>

 <tr>

  <td width="4%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>

  </td>

  <td width="33%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:33.08%;">

  <p align="left" style="margin:0in 0in .0001pt 17.3pt;text-align:left;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief Executive Officer</font></p>

  </td>

  <td width="21%" valign="top" style="padding:0in 0in 0in 0in;width:21.86%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;">&nbsp;</p>

  </td>

  <td width="4%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:4.6%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>

  </td>

  <td width="1%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:1.44%;">

  <p align="left" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:left;">&nbsp;</p>

  </td>

  <td width="34%" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:34.86%;">

  <p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">V.P., Legal and

  General Counsel</font></p>

  </td>

 </tr>

 <tr height="0">

  <td width="20" style="border:none;"></td>

  <td width="10" style="border:none;"></td>

  <td width="8" style="border:none;"></td>

  <td width="231" style="border:none;"></td>

  <td width="158" style="border:none;"></td>

  <td width="23" style="border:none;"></td>

  <td width="11" style="border:none;"></td>

  <td width="7" style="border:none;"></td>

  <td width="4" style="border:none;"></td>

  <td width="251" style="border:none;"></td>

 </tr>

</table>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='29',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;text-transform:uppercase;">Exhibit A</font></b></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CERTAIN

DEFINITIONS</font></b></p>



<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For purposes of the Agreement (including this

Exhibit&nbsp;A):</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Acquired Contracts</font></b>&#148;

shall have the meaning provided in Section&nbsp;2.4(a).</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Acquisition

Transaction</font></b>&#148; shall mean any transaction involving: (a) the sale or

other disposition of all or any portion of the Assets or Licensed Technology;

or (b) any merger, consolidation, business combination, share exchange,

reorganization or similar transaction involving Restoragen.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Affiliate</font></b>&#148;

shall mean an individual, trust, business trust, joint venture, partnership,

corporation, association or any other entity which (directly or indirectly) is

controlled by, controls or is under common control with a party to this

Agreement.&#160; For the purposes of this

definition, the term &#147;control&#148; (including, with correlative meanings, the terms

&#147;controlled by&#148; and &#147;under common control with&#148;) as used with respect to a

party, shall mean the possession (directly or indirectly) of at least fifty

percent (50%) of the outstanding voting securities of a corporation or

comparable equity interest in any other type of entity, or, where the laws of

the jurisdiction in which such entity operates prohibit ownership by a party of

fifty percent (50%), such ownership shall be at the maximum level of ownership

allowed by such jurisdiction.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Agreement</font></b>&#148;

shall mean the Asset Purchase and License Agreement to which this <b><i><font style="font-style:italic;font-weight:bold;">Exhibit&nbsp;A</font></i></b> is

attached (including the Disclosure Schedule and each other exhibit thereto), as

it may be amended from time to time.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Approval Order</font></b>&#148;

shall have the meaning provided in Section&nbsp;6.1.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Bankruptcy Court</font></b>&#148;

shall mean the United States Bankruptcy Court for the District of Nebraska.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Best Efforts</font></b>&#148;

shall mean the efforts that a prudent Person desiring to achieve a particular

result would use in order to ensure that such result is achieved as

expeditiously as possible.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Bill of Sale</font></b>&#148;

shall have the meaning provided in Section&nbsp;1.7(b)(i).</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">There shall be deemed to be a &#147;<b><font style="font-weight:bold;">Breach</font></b>&#148; of a representation, warranty,

covenant or obligation if there is or has been any inaccuracy in or breach

(including any inadvertent or innocent breach) of, or any failure (including

any inadvertent failure) to comply with or perform, such representation,

warranty, covenant, obligation or other provision.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Cardiovascular

Indication</font></b>&#148; shall mean indications for congestive heart failure and

peripheral vascular diseases associated with congestive heart failure, and

cardiac diseases.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='30',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;">&nbsp;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Code</font></b>&#148;

shall mean the Internal Revenue Code of 1986, as amended.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Confidential

Information</font></b>&#148; shall mean any confidential or proprietary information,

and any other information relating to any research project, work in process,

future development, scientific, engineering, manufacturing, marketing, business

plan, financial or personnel matter relating to either party, its present or

future products, sales, suppliers, customers, employees, investors or business,

whether in oral, written, graphic or electronic form.&#160; Prior to the Closing, the Assets and Licensed Technology shall be

deemed the Confidential Information of Restoragen.&#160; From and after the Closing, the Assets shall be deemed the

Confidential Information of Amylin, but the Licensed Technology shall remain

the Confidential Information of Restoragen.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Confidentiality

Agreement</font></b>&#148; shall have the meaning provided in Section&nbsp;11.1.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Consent</font></b>&#148;

shall mean any approval, consent, ratification, permission, waiver or

authorization (including any Governmental Authorization).</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Contract</font></b>&#148;

shall mean any written, oral, implied or other agreement, contract,

understanding, arrangement, instrument, note, guaranty, indemnity,

representation, warranty, deed, assignment, power of attorney, certificate,

purchase order, work order, insurance policy, benefit plan, commitment,

covenant, assurance or undertaking of any nature.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Control</font></b>&#148;

shall mean possession of the ability to grant a license without violating the

terms of any agreement or other arrangement with any Third Party.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">covered by</font></b>&#148;

shall mean, with respect to the Restoragen Patent Portfolio, that which would

infringe a Valid Claim or a claim in a pending patent application in the

Restoragen Patent Portfolio.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Development

Criteria</font></b>&#148; shall have the meaning provided in Section&nbsp;8.2.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Development Plan</font></b>&#148;

shall have the meaning provided in Section&nbsp;8.2.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Disclosure Schedule</font></b>&#148;

shall mean the schedule (dated as of the date of the Agreement) delivered to

Amylin on behalf of Restoragen, a copy of which is attached to the Agreement

and incorporated into the Agreement by reference.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Encumbrance</font></b>&#148;

shall mean any lien, pledge, charge, mortgage, security interest, claim,

preference, license, preemptive right, any other restriction on the transfer or

use of any Asset or Licensed Technology (other than non&#150;exclusive

licenses granted to Third Parties under the Licensed Technology).</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Entity</font></b>&#148;

shall mean any corporation (including any non-profit corporation), general

partnership, limited partnership, limited liability partnership, joint venture,

estate, trust, cooperative, foundation, society, political party, union,

company (including any limited liability company or joint stock company), firm

or other enterprise, association, organization or entity.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='31',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;">&nbsp;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Exendin</font></b>&#148;

shall mean exendin-3 or exendin-4.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">FDA</font></b>&#148;

shall mean the United States Food and Drug Administration, or any successor

agency thereto having the administrative authority to regulate the marketing of

human pharmaceutical products or biological therapeutic products, delivery

systems and devices in the United States of America.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">First Commercial

Sale</font></b>&#148; shall mean, with respect to any Product, the first sale for

end use or consumption of such Product in a country after the Regulatory

Authority of such country has granted Regulatory Approval of such Product.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">GLP-1</font></b>&#148;

shall mean glucagon like peptide-1 (7-36) amide.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">GLP-1 Product</font></b>&#148;

shall mean a pharmaceutical product the active ingredient of which is GLP-1 and

which is in a continuous infusion, extended release or other formulation the

manufacture, use, sale, offer for sale or import of which is covered by the

Restoragen Patent Portfolio or the Licensed Technology.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Governmental

Authorization</font></b>&#148; shall mean any: (a) permit, license, certificate,

franchise, concession, approval, consent, ratification, permission, clearance,

confirmation, endorsement, waiver, certification, designation, rating,

registration, qualification or authorization issued, granted, given or

otherwise made available by or under the authority of any Governmental Body or

pursuant to any Legal Requirement (including, without limitation, any

Regulatory Approval); or (b) right under any Contract with any Governmental

Body.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Governmental Body</font></b>&#148;

shall mean any: (a) nation, principality, state, commonwealth, province,

territory, county, municipality, district or other jurisdiction of any nature;

(b) federal, state, local, municipal, foreign or other government; (c)

governmental or quasi-governmental authority of any nature (including any

governmental division, subdivision, department, agency, bureau, branch, office,

commission, council, board, instrumentality, officer, official, representative,

organization, unit, body or Entity and any court or other tribunal);

(d)&nbsp;multi&#150;national organization or body; or (e) individual, Entity

or body exercising, or entitled to exercise, any executive, legislative,

judicial, administrative, regulatory, police, military or taxing authority or

power of any nature (including, without limitation, any Regulatory Authority).</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Intellectual

Property</font></b>&#148; shall mean data, formulae, inventions (whether or not

patentable), know-how, methods, processes, proprietary information, protocols,

specifications, techniques, and other forms of technology (whether or not

embodied in any tangible form and including all tangible embodiments of the

foregoing, such as laboratory notebooks, samples, studies and summaries).</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Intellectual

Property Rights</font></b>&#148; shall mean all past, present, and future rights of

the following types, which may exist or be created under the laws of any

jurisdiction in the world: (A)&nbsp;trade secret rights; (B) patent and

industrial property rights; (C) other proprietary rights in Intellectual

Property; and (D) rights in or relating to registrations, renewals, extensions,</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='32',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;">&nbsp;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">combinations, divisions, and reissues of, and applications for, any of

the rights referred to in clauses &#147;(A)&#148; through &#147;(C)&#148; above.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Know-How</font></b>&#148;

shall mean all know-how, trade secrets, data, processes, techniques,

procedures, compositions, devices, methods, formulas, protocols and

information, whether or not patentable, which (a)&nbsp;are Controlled by

Restoragen as of the Closing Date, (b)&nbsp;are necessary or useful for, or

contribute in whole or in part to, the practice of the Manufacturing Patents,

and (c)&nbsp;are not generally publicly known, but excluding the Assets.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Knowledge of

Restoragen</font></b>&#148; shall have the meaning provided in Section 16.15.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Legal Requirement</font></b>&#148;

shall mean any federal, state, local, municipal, foreign or other law, statute,

legislation, constitution, principle of common law, resolution, ordinance,

code, edict, decree, proclamation, treaty, convention, rule, regulation,

ruling, directive, pronouncement, requirement, specification, determination,

decision, opinion or interpretation issued, enacted, adopted, passed, approved,

promulgated, made, implemented or otherwise put into effect by or under the

authority of any Governmental Body.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Liability</font></b>&#148;

shall mean any debt, obligation, duty or liability of any nature (including any

unknown, undisclosed, unmatured, unaccrued, unasserted, contingent, indirect,

conditional, implied, vicarious, derivative, joint, several or secondary

liability), regardless of whether such debt, obligation, duty or liability

would be required to be disclosed on a balance sheet prepared in accordance

with generally accepted accounting principles and regardless of whether such

debt, obligation, duty or liability is immediately due and payable.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">License</font></b>&#148;

shall have the meaning provided in Section&nbsp;1.2.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Licensed Technology</font></b>&#148;

shall mean the Manufacturing Patents and the Know-How.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Manufacturing

Patents</font></b>&#148; shall mean (a)&nbsp;the patents and patent applications

listed on <b><i><font style="font-style:italic;font-weight:bold;">Exhibit&nbsp;F</font></i></b>

attached hereto, (b)&nbsp;any and all corresponding U.S. or foreign patents and

patent applications, whether now existing or hereafter filed, (c)&nbsp;any

provisionals, substitutions, divisionals, reissues, renewals, continuations,

continuations-in-part, substitute applications and inventors&#146; certificates arising

from, or based upon, any of the foregoing patents or patent applications, and

(d)&nbsp;any patents issuing from any of the foregoing patent applications.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">NDA</font></b>&#148;

shall mean a New Drug Application (as more fully defined in 21 C.F.R.

Part&nbsp;314.5 <i><font style="font-style:italic;">et seq</font></i>.) filed with

the FDA, or the equivalent application filed with any equivalent agency or

governmental authority outside the United States of America (including any

supra-national agency such as in the European Union).</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Net Sales</font></b>&#148;

shall mean the gross amount actually received by Amylin, its Affiliates and

sublicensees from Third Parties that are not Affiliates or sublicensees of the

selling party (unless such Affiliate or sublicensee is the end user of such

product, in which case the amount billed therefor shall be deemed to be an

amount that would be billed to a Third Party in an arm&#146;s-length transaction)

from sales of Products, less the following items, as allocable to such Product

(if not</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">33</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='33',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;">&nbsp;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">previously deducted from the amount invoiced): (i)&nbsp;trade

discounts, credits or allowances, (ii)&nbsp;credits or allowances additionally

granted upon returns, rejections or recalls, (iii)&nbsp;freight, shipping and

insurance charges, (iv)&nbsp;taxes, duties or other governmental tariffs (other

than income taxes) and (v)&nbsp;government mandated rebates.&#160; If a Product is sold or provided as part of

a system, package, or combination product or service that contains one or more

other active ingredients or other parts that could be sold separately (each, a

&#147;Combination Product&#148; and collectively, &#147;Combination Products&#148;), Net Sales

shall be calculated by multiplying the Net Sales received by Amylin, its

Affiliate or sublicensee from the sale of Combination Products by the fraction

A/B, where &#147;A&#148; is the fair market value of the Product when supplied or priced

separately and &#147;B&#148; is the fair market value of the Combination Product.&#160; In the event that no market price is

available for the Product when supplied or priced separately, fair market value

shall be determined in good faith by Amylin and Restoragen.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Order</font></b>&#148;

shall mean any: (a) order, judgment, injunction, edict, decree, ruling,

pronouncement, determination, decision, opinion, verdict, sentence, subpoena,

writ or award issued, made, entered, rendered or otherwise put into effect by

or under the authority of any court, administrative agency or other

Governmental Body or any arbitrator or arbitration panel; or (b) Contract with

any Governmental Body entered into in connection with any Proceeding.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Payment Term</font></b>&#148;

shall have the meaning provided in Section&nbsp;13.1.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Person</font></b>&#148;

shall mean any individual, Entity or Governmental Body.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Pre-Closing Period</font></b>&#148;

shall mean the period from the date of the Agreement through the Closing Date.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Proceeding</font></b>&#148;

shall mean any action, suit, litigation, arbitration, proceeding (including any

civil, criminal, administrative, investigative or appellate proceeding and any

informal proceeding), prosecution, contest, hearing, inquiry, inquest, audit,

examination or investigation commenced, brought, conducted or heard by or

before, or otherwise involving, any Governmental Body or any arbitrator or

arbitration panel.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Product</font></b>&#148;

shall mean a GLP-1 Product or Secondary Product, and &#147;<b><font style="font-weight:bold;">Products</font></b>&#148; shall mean GLP-1 Products and

Secondary Products.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Regulatory Approval</font></b>&#148;

shall mean any and all approvals (including price and reimbursement approvals),

licenses, registrations, or authorizations of the European Union or of any

country, federal, state or local regulatory agency, department, bureau or other

government entity that is necessary for the manufacture, use, storage, import,

transport and/or sale of a Product in such jurisdiction.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Regulatory

Authority</font></b>&#148; means, in a particular country or jurisdiction, any

applicable government regulatory authority involved in granting Regulatory

Approval and/or, to the extent required in such country or jurisdiction,

pricing or reimbursement approval of a Product in such country or jurisdiction,

including without limitation, the FDA and any foreign equivalent thereof.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">34</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='34',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;">&nbsp;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Representatives</font></b>&#148;

shall mean officers, directors, employees, agents, attorneys, accountants,

advisors and representatives.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Restoragen Patent

Portfolio</font></b>&#148; shall mean (a)&nbsp;the patents and patent applications

listed on <b><i><font style="font-style:italic;font-weight:bold;">Exhibit&nbsp;G</font></i></b>

attached hereto, (b)&nbsp;any and all corresponding U.S. or foreign patents and

patent applications, whether now existing or hereafter filed, (c)&nbsp;any

provisionals, substitutions, divisionals, reissues, renewals, continuations,

continuations-in-part, substitute applications and inventors&#146; certificates

arising from, or based upon, any of the foregoing patents or patent

applications, (d)&nbsp;any patents issuing from any of the foregoing patent

applications, and (e)&nbsp;any unfiled patent applications and written

inventions that pertain to GLP&#150;1, Exendins or analogues or agonists of

GLP&#150;1 or Exendins as of the Closing Date and any of the rights referred

to in clauses (a) through (d) above arising or resulting therefrom.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Royalty Term</font></b>&#148;

shall have the meaning provided in Section&nbsp;9.2.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Secondary Product</font></b>&#148;

shall mean a pharmaceutical product the active ingredient of which is an

Exendin or an analogue or agonist of GLP&#150;1 or an Exendin the manufacture,

use, sale, offer for sale or import of which is covered by the Restoragen

Patent Portfolio.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Side Letters</font></b>&#148;

shall mean those certain letter agreements dated as of the date set forth in

the opening paragraph of this Agreement among Amylin, Restoragen and Drs. David

Hathaway and Roberta Schneider.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Study</font></b>&#148;

shall mean the ongoing study R02-C901 of GLP-1 Product.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Study Data</font></b>&#148;

shall have the meaning provided in Section&nbsp;8.2.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Study Report</font></b>&#148;

shall mean the final study report from the Study, including, without

limitation, data from patients in the reference group referenced therein.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Tax</font></b>&#148;

shall mean any tax (including any income tax, franchise tax, capital gains tax,

estimated tax, gross receipts tax, value-added tax, surtax, excise tax, ad

valorem tax, transfer tax, stamp tax, sales tax, use tax, property tax, business

tax, occupation tax, inventory tax, occupancy tax, withholding tax or payroll

tax), levy, assessment, tariff, impost, imposition, toll, duty (including any

customs duty), deficiency or fee, and any related charge or amount (including

any fine, penalty or interest), that is, has been or may in the future be

(a)&nbsp;imposed, assessed or collected by or under the authority of any

Governmental Body, or (b)&nbsp;payable pursuant to any tax&#150;sharing

agreement or similar Contract.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Tax Return</font></b>&#148;

shall mean any return (including any information return), report, statement,

declaration, estimate, schedule, notice, notification, form, election,

certificate or other document or information that is, has been or may in the

future be filed with or submitted to, or required to be filed with or submitted

to, any Governmental Body in connection with the determination, assessment,

collection or payment of any Tax or in connection with the administration,

implementation or enforcement of or compliance with any Legal Requirement relating

to any Tax.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">35</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='35',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;">&nbsp;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Third Party</font></b>&#148;

shall mean any entity other than Restoragen or Amylin or an Affiliate of

Restoragen or Amylin.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Transactional

Agreements</font></b>&#148; shall mean: (a) the Agreement; (b)&nbsp;the Closing Certificate;

and (c)&nbsp;the Bill of Sale.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Transactions</font></b>&#148;

shall mean (a)&nbsp;the execution and delivery of the respective Transactional

Agreements, and (b)&nbsp;all of the transactions contemplated by the respective

Transactional Agreements, including: (i) the sale of the Assets by Restoragen

to Amylin in accordance with the Agreement; (ii)&nbsp;the grant of the License;

and (iii) the performance by Restoragen, Amylin of their respective obligations

under the Transactional Agreements, and the exercise by Restoragen, Amylin of their

respective rights under the Transactional Agreements.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<b><font style="font-weight:bold;">Valid Claim</font></b>&#148;

shall mean a claim of an issued patent, which claim has not lapsed, been

canceled or become abandoned and has not been declared invalid or unenforceable

by an unreversed and unappealable decision or judgment of a court or other

appropriate body of competent jurisdiction.</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">36</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='36',FILE='C:\C2\jbigham\7231_1\t_1176491\j7231_ex2d1.htm',USER='jbigham',CD='Feb 11 05:42 2003' -->
<br clear="all" style="page-break-before:always;">

</font>



<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:justify;">&nbsp;</p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following Exhibits to the Asset Purchase Agreement have been

omitted:</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit B &#150; Assets</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit B-1 &#150; GLP-1 Product Inventory</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit C &#150; Assumed Liabilities</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit D &#150; Form of Bill of Sale, Assignment and

Assumption</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit E &#150; Development Criteria</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit F &#150; Manufacturing Patents</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit G &#150; Restoragen Patent Portfolio</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p style="margin:0in 0in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Restoragen, Inc. hereby agrees to supplementally furnish a copy of any

omitted schedule or exhibit upon the request of the Commission.</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>



<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37</font></p>





<div align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">



<hr size="2" width="100%" noshade color="gray" align="left">



</font></div>



</div>



</body>



</html>

</TEXT>
</DOCUMENT>
